DIABETES MELLITUS IN MALAYSIA
This bibliography is a collection of Malaysian research/publications on diabetes mellitus. The search method
follows the method that has been previously described.[1] In brief, clinical research publications containing data
on Malaysia for the period 2000-2014 were included (last search date 28 Dec 2014). We have included conference
proceedings (but not conference abstracts), relevant theses/dissertation, books/book chapters, reports and clinical
practice guidelines. Where available, link to free full text is provided.
In view of the large number of items (n=679), this bibliography is divided into the seven parts.
1. Diabetes mellitus, type 2 [Mesh term: Diabetes Mellitus, Type 2]
2. Diabetes mellitus, type 1 [Mesh term: Diabetes Mellitus, Type 1]
3. Gestational diabetes and diabetes in pregnancy [Mesh term: Diabetes, Gestational]
4. Diabetic nephropathy [Mesh term: Diabetic Nephropathies]
5. Diabetic neuropathy [Mesh term: Diabetic Neuropathies]
6. Diabetic retinopathy [Mesh term: Diabetic Retinopathy]
7. Diabetic foot [Mesh term: Diabetic Foot]
The preparation of this bibliography is funded by a grant from National Clinical Research Centre to International
Medical University (Project ID No. IMU R 150/2014). The project leader is Professor CL Teng. Searchers were made
by CL Teng, Zuhanariah Mohd Nordin, Goh Cheng Chun and Ng Chun Sien. Kindly send enquiry about this
bibliography to tengcl@gmail.com
Reference:
1. Teng CL, Zuhanariah MN, Ng CS, et al. Bibliography of clinical research in Malaysia: methods and brief
results. Med J Malaysia 2014;69 Suppl A:4-7
http://www.e-mjm.org/2014/supplement-A/bibliography-of-clinical-research-in-Malaysia.pdf.
PART 1: DIABETES MELLITUS, TYPE 2
Books, Book Chapters, Guidelines, Reports, Proceedings
1. Abdol Malek AA, Mohamed Mansor M, Salmah B, et al. Drug Utilization in the Treatment of Diabetes
Mellitus in the Ministry of Health Facilities. Kuala Lumpur: Ministry of Health, Malaysia, 2013
http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/drug-utilization-treatmentdiabetes-mellitus-moh-malaysia.pdf
2. Abida Haq, Syed M. Haq, Nurul Adha O, Tengku Malini, Tengku Mohamed Noor Izam, Ratna Suny ME.
Protocol Medication Therapy Adherence Clinic: Diabetes. Kuala Lumpur: Ministry of Health, Malaysia,
2010
http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/drug-utilization-treatmentdiabetes-mellitus-moh-malaysia.pdf
3. Annual Report of the Diabetes in Children & Adolescent Registry (DiCARE) 2006-2007. Kuala Lumpur:
Ministry of Health, 2008
4. Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus, Fourth Edition. Kuala Lumpur:
Ministry of Health, Malaysia, 2009. http://www.acadmed.org.my/view_file.cfm?fileid=292
5. Diabetes Registry Malaysia: report of an audit of diabetes control and management (January-December
2009). Kuala Lumpur: Clinical Research Centre, 2010
6. Feisul Idzwan M, Fatanah I, Nor Azlina AR. The burden of diabetes mellitus and its related complications in
government hospitals in Malaysia (1999-2004). Putrajaya: Ministry of Health, Malaysia, 2007
7. Health technology assessment report: Management of diabetes melitus and screening for
microalbuminuria in diabetics. Kuala Lumpur: Ministry of Health, Malaysia, 2004
http://www.moh.gov.my/attachments/713.pdf
8. Medical Nutrition Therapy Guideline for Type 2 Diabetes, Second Edition. Malaysian Dietitians'
Association, 2013
9. National Diabetes Registry Report, Volume 1 2009-2012. Ministry of Health, Malaysia, 2013
10. Noormah MD, Roza S. Health technology assessment report: Nutritional therapy as a complement for
diabetes and hypertension. Kuala Lumpur: Ministry of Health, Malaysia, 2013
http://www.moh.gov.my/hta/Nutritional_Therapy_report.pdf
11. Practical Guide to Insulin Therapy in Type 2 Diabetes Mellitus. Ministry of Health, Malaysia, 2011
12. User Manual: Diabetes clinical audit in health facilities. [Manual pengguna. Audit klinikal diabetes di fasiliti
kesihatan]. Kuala Lumpur: Ministry of Health, Malaysia, 2008
13. Wan Mohamad WB, Mastura I. Preliminary report of an audit of diabetes control and management (DRMADCM) July to December 2008. Kuala Lumpur: Diabetes Registry Malaysia, 2009
14. Wan Mohamad WB. Diabetes in Malaysia: Complications and Treatment. [Diabetes di Malaysia:
Komplikasi dan Rawatan]. Pulau Pinang: Penerbit Universiti Sains Malaysia, 2005
Dissertations, Theses
1. Abdul Majeed SAR. Evaluation of coronary heart disease risk among patients with type 2 diabetes in
Hospital Pulau Pinang, Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2011.
2. Abdul Rahman H. Body mass index and its associated morbidity among elderly patients attending Klinik
Kesihatan Parit Jawa, Muar. Dissertation, Universiti Kebangsaan Malaysia, 2000.
3. Abougalambou SSI. Assessment of the clinical treatment outcomes and direct medical costs among type 2
diabetes mellitus outpatients at the Hospital Universiti Sains Malaysia. PhD Thesis, Universiti Sains
Malaysia, 2011.
4. Ahmad Ihsan AB. Prevalence of testosterone deficiency syndrome among men with type 2 diabetes in
primary care clinic, University Malaya Medical Centre. M Fam Med Dissertation, University of Malaya,
2012.
5. Ahmad Iskandar Zulkarnain J. Oculo-visual status of diabetics experiencing prolonged hyperglycaemia.
[Status okular dan visual pesakit diabetes tanpa retinopati yang mengalami hiperglisemia berpanjangan].
Master Dissertation, Universiti Kebangsaan Malaysia, 2000.
http://ptsldigital.ukm.my:8080/vital/access/services/Download/ukmvital:119/ABSTRACT
6. Ajay M. Vascular effects of flavonoids in hypertension and diabetes mellitus. PhD Thesis, University of
Malaya, 2006.
7. Akmal Naziah A. Factors influencing glycaemic control in older people with type 2 diabetes mellitus on
oral hypoglycaemic therapy and attending a primary health care centre in Negeri Sembilan, Malaysia. MSc
Dissertation, Universiti Putra Malaysia, 2011. http://psasir.upm.edu.my/19677/1/IG_2011_1.pdf
8. Al-anbari HSN. Evaluation of metformin usage in treatment of patients with type-2 diabetes mellitus in
Penang General Hospital. MSc (Pharmacy) Dissertation, Universiti Sains Malaysia, 2008.
http://eprints.usm.my/10179/1/EVALUATION_OF_METFORMIN_USAGE_IN.pdf
9. Al-Hamodi ZH. Genetic polymorphisms of plasminogen activator inhibitor-1 and tissue plasminogen
activator in Malaysian subjects with type 2 diabetes. PhD Thesis, University of Malaya, 2012.
10. Al-Maweri, Sadeq Ali Ali Mohammed. Prevalence of oral mucosal lesions and the association between
diabetes mellitus and oral precancerous lesions among Malay patients attending Hospital Universiti Sains
Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2009.
11. Alnajjar BOM. Computer-aided drug design of novel peroxisome proliferator-activated receptor gamma
activators for the treatment of type 2 diabetes mellitus. PhD Thesis, Universiti Sains Malaysia, 2012.
12. al-Qazaz HKM. Assessment of knowledge and adherence to medication: a mixed methodology study
among patients with type-2 diabetes mellitus in Penang. PhD Thesis, Universiti Sains Malaysia, 2011.
13. Al-Zurfi BMN. Selected anthropometric parameters in relation to glycaemic control and associated factors
in Malay diabetic type 2 patients in HUSM. MSc Dissertation, Universiti Sains Malaysia, 2010.
14. Amrizal MN. A cost analysis of diabetes mellitus, pre-eclampsia and neonatal jaundice in Hospital
Universiti Sains Malaysia, Kubang Kerian. [Kajian kos rawatan pesakit bagi ketiga-tiga penyakit diabetes
mellitus, pre-eklampsia dan neonatal jaundis di Hospital Universiti Sains Malaysia, Kubang Kerian.]. MPH
Dissertation, Universiti Sains Malaysia, 2009.
15. Chan HH. Salivary protein profiling for type 2 diabetes mellitus patients with and without periodontitis. M
Dent Sc Dissertation, University of Malaya, 2013.
16. Choo AJ. Data analysis for diabetic patients. MSc Dissertation, Universiti Sains Malaysia, 2004.
17. Dharmendra H. The serological prevalence of Burkholderia pseudomallei infection among asymptomatic
patients with diabetes mellitus who are attending the outpatient medical specialist clinic in University
Malaya Medical Centre. Dissertation, University of Malaya, 2001.
18. Eid Mohammad AM. Factors affecting diabetes control and dyslipidaemia among type 2 diabetes mellitus
patients in Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia,
2003.http://eprints.usm.my/5569/1/Kaewalan_Diabetes_Dan_Dyslipidaemia.pdf
19. Elhadi IE. Identification of factors affecting blood pressure control in patients admitted with hypertension
in Penang General Hospital. Master of Science (Pharmacy), Universiti Sains Malaysia, 2007.
http://eprints.usm.my/9650/1/IDENTIFICATION_OF_FACTORS_AFFECTING_BLOOD_PRESSURE_CONTROL
_IN_PATIENTS_ADMITTED_WITH_HYPERTENSION_IN_PENANG_GENERAL_HOSPITAL.pdf.
20. Habshoh H. Prevalence of depression and associated factors in type 2 diabetes mellitus patients attending
outpatient clinic Pendang Health Centre, Kedah Darulaman. M Fam Med Dissertation, Universiti
Kebangsaan Malaysia, 2000.
21. Haryati H. A study on glycemic control among insulin-treated type 2 diabetes patients attending diabetes
centre, HUSM, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2009.
22. Hasni I. Use of HbA1c in the diagnosis of type 2 diabetes mellitus in high risk group attending Klinik
Rawatan Keluarga Hospital Universiti Sains Malaysia.MSc Dissertation, Universiti Sains Malaysia,
2006.http://eprints.usm.my/8288/1/STUDIES_ON_DIABETIC_AND_PREDIABETIC_VASCULAR_DISEASE_AN
D_THE_EFFECT_OF_SELECTED_THERAPEUTIC_MODALITIES_ON_ASSOCIATED_VASCULOPATHY.pdf;.
23. Hasniza H. Prevalence of falls and its associates factors among elderly diabetes attending Klinik Pakar
Perubatan and Klinik Rawatan Keluarga Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti
Sains Malaysia, 2009.
24. Hazizi AS. Cardiovascular disease risk factors among type 2 diabetes and normal individuals. PhD Thesis,
Universiti Putra Malaysia, 2010. http://psasir.upm.edu.my/6611/1/FPSK%28P%29_2006_2A.pdf
25. Hazlin M. Medication nonadherence among patients with type 2 diabetes mellitus attending a primary
care clinic. MFamMed Dissertation, University of Malaya, 2012.
26. Ho BK. The association of central obesity with hypercholesterolemia. MFamMed Dissertation, University
of Malaya, 2000.
27. Ikhwan Sani M. Post operative morbidity and 3 years survival rate in diabetic and non diabetic patients
undergoing coronary artery bypass grafting in Hospital Universiti Sains Malaysia. MSc Dissertation,
Universiti Sains Malaysia, 2009.
28. Ishaq Aweis DM. Clinical outcomes and economic burden of patients having diabetes mellitus and
tuberculosis in three hospitals in Malaysia. PhD Thesis, Universiti Sains Malaysia, 2011.
29. Izzul Syazwan S. Initiation Of Insulin In Type 2 Diabetes Mellitus Patient. Bachelor of Pharmacy
Dissertation, Universiti Teknologi MARA,
2010.http://eprints.uitm.edu.my/2219/1/IZZUL_SYAZWAN_SHUIB_10_24.pdf.
30. Johan RI. Serum neurophil gelatinase-associated lipocalin (NGAL) characteristics in diabetic patients with
renal impairment undergoing elective coronary angiogram in University Malaya Medical Centre. M Int
Med Dissertation, University of Malaya, 2012.
31. Kamarul Imran M. The validation of the Malay translated audit of diabetes-dependent quality of life
(ADDQOL). MSc Dissertation, Universiti Sains Malaysia, 2005.
32. Kareem Hamoodi H. Evaluation of type-2, diabetes mellitus among hepatitis B and C patients in Penang
General Hospital, Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2011.
33. Koo HC. A multiethnic study to determine the association of dietary intake and physical activity with
plasma adiponectin concentrations among type 2 diabetis mellitus patients in Penang. MSc Dissertation,
Universiti Sains Malaysia, 2012.
34. Kow FF. Dietary adherence and health belief among Malay with type 2 diabetes mellitus patients in the
Diabetes Centre, Hospital Universiti Sains Malaysia (HUSM). Dissertation, Universiti Sains Malaysia, 2009.
35. Lau WK. Development of cell-free assay system for the screening of PPAR-gamma ligands from natural
products: in search for positive therapeutic agents for type 2 diabetes. PhD Thesis, Universiti Sains
Malaysia, 2013.
36. Lee CS. The association of Fatty Acid Binding Protein polymorphism with obesity and type 2 diabetes
mellitus in Malaysian subjects. MMedSc Dissertation, University of Malaya, 2010.
37. Loh BI. The association of glycemic index and dietary fiber with plasma adiponectin and leptin
concentrations among multiethnic patients with type 2 diabetes mellitus in Penang general hospital. MSc
Dissertation, Universiti Sains Malaysia, 2013.
38. Luqman I. Urine bisphenol A level in patients with diabetes mellitus and metabolic syndrome. M Int Med
Dissertation, University of Malaya, 2012.
39. Mahmoud Sa’di MA. Economic, social and clinical evaluations of diabetes self management program at
Universiti Sains Malaysia Health Center: comparison between structured and less structured educational
programs. PhD Thesis, Universiti Sains Malaysia, 2008.
http://eprints.usm.my/8954/1/ECONOMIC%2C_SOCIAL_AND_CLINICAL_EVALUATIONS_OF_DIABETES_SE
LF_MANAGEMENT_PROGRAM_AT_UNIVERSITI_SAINS_MALAYSIA_HEALTH_CENTER.pdf.
40. Malik A. Influence of platelet rich plasma on osseointegration in controlled diabetic patients. MSc
Dissertation, Universiti Sains Malaysia, 2008.
41. Mardhiah A, Chua, SS and Chan, SP. Common problems associated with the use of hypoglycaemic agents
by diabetic patients. Dissertation, 2005.
42. Marilyn U. A cross sectional study on quality of life among non-insulin dependent diabetes mellitus
patients in Sarikei, Sarawak. Master Dissertation, Universiti Kebangsaan Malaysia, 2007.
43. Mohamad Azfar Z. A comparison of quality of life based on Malay version audit of diabetes-dependent
quality of life (Malay ADDQL) scores between type 2 diabetes mellitus patients on oral hypoglycemic
agent only treatment versus insulin only or combined insulin and oral hypoglycemic agent treatment in
HUSM Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2011.
44. Mohamed Awad AAM. Pharmacoepidemiologic and direct medical cost evaluations of type 2 diabetes
mellitus in Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2005.
45. Mohamed AAAE. The impact of compliance of the prescribers to the Malaysian consensus for type 2
diabetes mellitus management for hospitalized Penang hospital's patients and their self management.
MSc Dissertation, Universiti Sains Malaysia, 2009.
46. Mohd Dziehan M. Beliefs about medicine and medication adherence among malay patients with type 2
diabetes mellitus in primary health care. Master of Pharmacy Practice, Universiti Teknologi MARA,
2010.http://eprints.uitm.edu.my/7434/1/MOHD%20DZIEHAN%20MUSTAPA%2010_24.pdf
47. Moy FM. Nutritional status, knowledge, attitude and practice of type 2 diabetes patients. [Status
pemakanan dan tahap pengetahuan sikap dan amalan pesakit diabetes jenis 2]. Master Dissertation,
Universiti Kebangsaan Malaysia, 2000.
48. Muhammad Huzaimi H. Association of TCF7L2 variants with type 2 diabetes mellitus susceptibility and
treatment outcome in multi-ethnic Malaysian population. MMedSc Dissertation, University of Malaya,
2012.
49. Nik Sherina Haidi H. Continuity of care: Assessment of provider continuity and its impact on diabetes
mellitus in family practice. MFamMed Dissertation, University of Malaya, 2000.
50. Noor Hasliza H. A study on the effect of oral hypoglycaemic agents on arterial stiffness among Malay
patients with type 2 diabetes mellitus. MSc Dissertation, Universiti Sains Malaysia, 2006.
51. Noor Hasnita IM. Intrarenal resistive index (RI) in type 2 diabetes mellitus: correlation with creatinine
clearance and association with urinary albumin excretion. MSc Dissertation, Universiti Sains Malaysia,
2009.
52. Nor Azwany Y. A study of the knowledge, attitude and practice and the effect of ramadan fasting on
glycemic control and hydration status of type 2 diabetic patients in Hospital Universiti Sains Malaysia,
Kubang Kerian, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2003.
53. Nor Masniwati S. Evaluation of visual function, mascular thickness and quality of life pre and post focal
laser photocoagulation in diabetic macular oedema. MMed Dissertation, Universiti Sains Malaysia, 2012.
54. Norazlin AK. A comparative study on economic burden between schizophrenia and diabetes mellitus in
Malaysian secondary hospital. MSc Dissertation, Universiti Sains Malaysia, 2010.
55. Norhidayah MJ. Diabetes diagnosis and monitoring web based using Decision Support System (DSS)
approach. BSc Dissertation, Universiti Teknologi MARA, 2005.
http://eprints.uitm.edu.my/10435/1/NORHIDAYAH%20BINTI%20MOHD%20JUSOH%2005_24.pdf.
56. Nur Aqilah AR. Quality of life of type 2 diabetes mellitus (T2DM) patients in the endocrine clinic of
Hospital Putrajaya. Bachelor of Pharmacy Dissertation, Universiti Teknologi MARA,
2010.http://eprints.uitm.edu.my/2248/1/NUR_AQILAH_ABDUL_RAHMAN_10_24.pdf.
57. Nurkhairizan K. Pendekatan penaakulan berasaskan perancangan menu pemakanan pesakit diabetes.
Master Dissertation, Universiti Kebangsaan Malaysia, 2008.
58. Nursazwina AS. Development of web based fuzzy expert system for disease diagnosis: diabetes diagnosis
system. BSc Dissertation, Universiti Teknologi MARA,
2006.http://eprints.uitm.edu.my/2219/1/IZZUL_SYAZWAN_SHUIB_10_24.pdf;;.
59. Nurul Akmar G. Risk of coronary heart disease in type 2 diabetes mellitus patients in Kelantan. MSc
Dissertation, Universiti Sains Malaysia, 2011.
60. Nurul Azreen H. Depression and quality of life in patients with type 2 diabetes mellitus. MPM Dissertation,
University of Malaya, 2011.
61. Ooi CP. Application of a social cognitive theory model to analyse hypoglycaemic risk factors in older
patients with type 2 diabetes in two rural primary healthcare clinics in Selangor, Malaysia. PhD Thesis,
Universiti Putra Malaysia, 2010. http://psasir.upm.edu.my/27002/1/IG%202011%204R.pdf.
62. Phang LL, Chua, SS and Chan, SP. Factors associated with medication adherence of type 2 diabetic patients
and the role of healthcare providers. Dissertation, University of Malaya, 2006.
63. Rafidah G. Sistem pengkomputeran pengurusan diet bagi diabetes mellitus: pengenalpastian keperluan
maklumat, pembangunan sistem dan evaluasi formatif. Master Dissertation, Universiti Kebangsaan
Malaysia, 2005.
64. Raja Elina Afzan, Raja Ahmad. Determinants of exercise capacity in patients with uncomplicated type 2
diabetes mellitus. MMedSc Dissertation, University of Malaya, 2005.
65. Renukanth PCR. Effect of periodontal intervention on periodontal disease and type 2 diabetes mellitus. M
Clin Dent (Periodontology) Dissertation, University of Malaya, 2011.
66. Rosediani M. Assessing glycaemic control: a randomized control trial between fasting and 2 hours
postprandial blood glucose monitoring in type 2 diabetic patients attending Klinik Rawatan Keluarga,
Universiti Sains Malaysia, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2005.
67. Rosmiza A. Prevalence of chronic kidney disease and its associated factors in type 2 diabetes mellitus.
MFamMed Dissertation, University of Malaya, 2011.
68. Rozanah AR. Prevalence and associated risk factors of clostridium difficile infection in type 2 diabetes
mellitus patients treated with antibiotics. MSc Dissertation, Universiti Sains Malaysia, 2010.
69. Salem SDH. Association of genetic polymorphism of hhex, igf2bp2 and slc30a8 with glutamic acid
decarboxylase antibody-negative diabetes and latent autoimmune diabetes in adults (LADA) in
Malaysians. MMedSc Dissertation, University of Malaya, 2013.
70. Salmiah MA. Type 2 diabetes in Malaysia: perspectives of Malay patients and their health care
professionals. PhD Thesis, University of Nottingham, 2006.
71. Samitah Z. Studies to determine the prevalence of candidate gene polymorphism and their association
with arterial stiffness in diabetes mellitus among Malays. MSc Dissertation, Universiti Sains Malaysia,
2007.
72. Sayeeda R. Studies on diabetic and prediabetic vascular disease and the effect of selected therapeutic
modalities on associated vasculopathy. PhD Thesis, Universiti Sains Malaysia,
2006.http://eprints.usm.my/8288/1/STUDIES_ON_DIABETIC_AND_PREDIABETIC_VASCULAR_DISEASE_AN
D_THE_EFFECT_OF_SELECTED_THERAPEUTIC_MODALITIES_ON_ASSOCIATED_VASCULOPATHY.pdf.
73. Sharifah Izwan TO. Polymorphism of beta3-adrenergic receptor, leptin receptor, glucocorticoid receptor
and tumour necrosis factor-alpha gene among patients with type 2 diabetes mellitus. [Polimorfisma gen
reseptor β3-adrenergik, gen reseptor leptin, gen reseptor glukokortikoid dan gen faktor nekrosis tumor-α
pada pesakit diabetes melitus jenis 2]. PhD Thesis, Universiti Sains Malaysia,
2010.http://eprints.usm.my/9776/1/POLIMORFISMA_GEN_RESEPTOR_%CE%B23ADRENERGIK%2C_GEN_RESEPTOR_LEPTIN%2C_GEN_RESEPTOR_GLUKOKORTIKOID_DAN_GEN_FAKTOR.p
df.
74. Shori AB. Inhibitory potential of Azadirchta indica-enriched yogurt against key enzymes linked to type-2
diabetes and hypertension. MSc Dissertation, University of Malaya, 2009.
75. Shubashini G. Pharmaceutical care for patients with tuberculosis and diabetes mellitus in Malaysia : a
complex intervention. PhD Thesis, University of Nottingham, 2012.
76. Sim SK. Oxidative dna damage in leukocytes and its association with metabolic control in diabetic patients
with and without microalbuminuria. MSc Dissertation, Universiti Putra Malaysia,
2001.http://psasir.upm.edu.my/11220/1/FPSK_M_2001_8_A.pdf.
77. Siti Rafiaah I. Prevalence of glucose intolerance and factors that influence it among pregnant women with
and without risk at Antenatal Clinic, HUKM. Dissertation, Universiti Kebangsaan Malaysia, 2000.
78. Sudzilla N. Antiproteinuric effect of Rasilez (aliskiren) in hypertensive/normotensive type 2 diabetes
added on to ACEI base treatment. MMed Dissertation, Universiti Sains Malaysia, 2013.
79. Suhaimi MI. Erectile dysfunction among diabetic patients attending Diabetic Clinic, Klinik Kesihatan
Bandar, Kota Bharu and Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan. Dissertation,
Universiti Sains Malaysia, 2002.
80. Suhaiza S. The impact of structured healthy lifestyle programs among type 2 diabetic patients in Pasir
Puteh, Kelantan: a controlled trial .MSc Dissertation, Universiti Sains Malaysia, 2001.
81. Sukhbir KJS. A study of glycaemic control and the associated factors among diabetic patients at the Sungai
Dua Health Clinic Penang. Dissertation, Universiti Kebangsaan Malaysia, 2000.
82. Sulaila B. A study on the effects of Andrographis paniculata (hempedu bumi) on serum protein C, protein S
activity and fasting blood glucose in patients with type 2 diabetes mellitus. MMed Dissertation, Universiti
Sains Malaysia, 2011.
83. Suraya M. Factors associated with unawarness of correct FBG target among type 2 diabetes mellitus
patients in Hospital Universiti Sains Malaysia. MMed Dissertation, Universiti Sains Malaysia, 2012.
84. Tan MY. Self-care practices of adults with poorly controlled diabetes mellitus in Malaysia. Doctorate in
Nursing Thesis, University of Adelaide, 2009.
http://digital.library.adelaide.edu.au/dspace/bitstream/2440/57031/1/02whole.pdf.
85. Tan SF. Decline rate of kidney function in patients with type 2 diabetes mellitus and the associated factors
- a 10-year retrospective cohort study. MFamMed Dissertation, University of Malaya, 2012.
86. Tengku Ahmad Damitri Al-Astani TD. Expression of apoptosis markers in the skin microvasculature of
patients with diabetes mellitus type 2 at Hospital Universiti Sains Malaysia. MSc Dissertation (Pathology),
Universiti Sains Malaysia,
2008.http://eprints.usm.my/9891/1/EXPRESSION_OF_APOPTOSIS_MARKERS_IN_THE_SKIN_MICROVASC
ULATURE_OF_PATIENTS_WITH_DIABETES_MELLITUS_TYPE_2_AT_HOSPITAL_UNIVERSITI_SAINS_MALAYSI
A.pdf.
87. Tengku Norbanee TH. A study of microalbuminuria and associated factors in patients with type 2 diabetes
mellitus in Hospital Universiti Sains Malaysia, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2003.
88. Vasudevan R. Analysis of Genetic Polymorphisms as Risk Factors in Essential Hypertension and Type 2
Diabetes Mellitus among Malaysians. PhD Thesis, Universiti Putra Malaysia, 2009.
http://psasir.upm.edu.my/7122/.
89. Vithyatheri G. A system for diagnosing diabetic patients using rule-based reasoning. M Comp Sc
Dissertation, University of Malaya, 2011.
90. Wan Syamimee WG. Combination therapy for optimum glycaemic control: a randomized open label trial
comparing rosiglitazone with combination sulphonylureas and metformin tablets in type 2 diabetes
mellitus. MSc Dissertation, Universiti Sains Malaysia, 2006.
91. Yusliza Azreen MY. A study on the effect of cabergoline in patients with type 2 diabetes mellitus and
metabolic syndrome. MMed Dissertation, Universiti Sains Malaysia, 2013.
92. Zaki Ghaith NF. Evaluation of combined metformin-lovastatin therapy in the treatment of diabetic type 2
patients with dyslipidemia in Hospital Pulau Pinang. MSc Dissertation, Universiti Sains Malaysia, 2010.
93. Zukri MA. The quality of care and complications status among patients with 15 years history of diabetes
mellitus in HUSM. MSc Dissertation, Universiti Sains Malaysia, 2005.
Reviews, Editorials, Commentaries
1. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Osteoporosis and type 2 diabetes mellitus: what do
we know, and what we can do? Patient Prefer Adherence 2012;6:435-48
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
http://www.dovepress.com/osteoporosis-and-type-2-diabetes-mellitus-what-do-we-know-and-what-we-peer-reviewed-article-PPA
Amudha K, Sivalal S, Ng SH. Social support in type II diabetes care: a case of too little, too late. Diabetes
Metab Syndr Obes 2012;5:407-17
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514066
Anuar Zaini MZ. Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus? Diabetes Res
Clin Pract 2000;50 Suppl 2:S23-8
Balakumar P, Sundram K, Dhanaraj SA. Dapagliflozin: Glucuretic action and beyond. Pharmacol Res
2014;82:34-9
Chan JCN, Chan SP, Deerochanawong C, et al. Diabetic dyslipidaemia in Asian populations in the Western
Pacific Region: what we know and don't know. Diabetes Res Clin Pract 2011;94(1):1-13
Erejuwa OO, Siti Amrah S, Mohd Suhaimi AW. Honey--a novel antidiabetic agent. Int J Biol Sci
2012;8(6):913-34
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399220/pdf/ijbsv08p0913.pdf
Erejuwa OO, Siti Amrah S, Mohd Suhaimi AW. Oligosaccharides might contribute to the antidiabetic effect
of honey: a review of the literature. Molecules 2011;17(1):248-66
Haghverdizadeh P, Haerian M, Haghverdizadeh P, et al. ABCC8 genetic variants and risk of diabetes
mellitus. Gene 2014;545(2):198-204
Hanis HH, Morris MJ, Kavurma MM. On the TRAIL of obesity and diabetes. Trends Endocrinol Metab
2013;24(11):578-87
Jeyamalar R, Lopez EA, Rahajoe AU, et al. Women's cardiovascular health: perspectives from South-East
Asia. Nat Rev Cardiol 2012;9(8):464-77
Kavitha N, De S, Kanagasabai S. Oral hypoglycemic agents in pregnancy: An update. J Obstet Gynaecol
India 2013;63(2):82-7
Khaled AA, Sekaran M, Ikram Shah I. N(epsilon)-(carboxymethyl)lysine and coronary atherosclerosisassociated low density lipoprotein abnormalities in type 2 diabetes: current status. J Clin Biochem Nutr
2009;44(1):14-27
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613495
Laitiff AA, Teoh SL, Das S. Wound healing in diabetes mellitus: traditional treatment modalities. Clin Ter.
2010;161(4):359-64
Liew AKC, Punnanithinont N, Lee YC, et al. Effect of non-surgical periodontal treatment on HbA1c: a metaanalysis of randomized controlled trials. Aust Dent J 2013;58(3):350-7
Lock JH, Fong KC. Retinal laser photocoagulation. Med J Malaysia 2010;65(1):88,94; quiz 95
http://www.e-mjm.org/2010/v65n1/Retinal_Laser_Photocoagulation.pdf
Lye HS, Kuan CY, Ewe JA, et al. The improvement of hypertension by probiotics: effects on cholesterol,
diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10(9):3755-75
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769158
Maimunah M, Mazza D. Preconception care of women with diabetes: a review of current guideline
recommendations. BMC Womens Health 2010;10:5,6874-10-5
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834595
Mafauzy M. Diabetes mellitus in Malaysia. Med J Malaysia 2006;61(4):397-8
http://www.e-mjm.org/2006/v61n4/Diabetes_Mellitus_Malaysia.pdf
Mustaffa E. Diabetes epidemic in Malaysia. Med J Malaysia 2004;59(3):295-6
http://www.e-mjm.org/2004/v59n3/Diabetes.pdf
Masakazu T, Kousuke O, Tatsuya T, et al. Ethnic difference in patients with type 2 diabetes mellitus in
inter-East Asian populations: a systematic review and meta-analysis focusing on fasting serum insulin.
Diabetes Res Clin Pract 2008;81(3):370-6
Matough FA, Siti B B, Zariyantey AH, et al. The role of oxidative stress and antioxidants in diabetic
complications. Sultan Qaboos Univ Med J 2012;12(1):5-18
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286717/pdf/squmj-12-5.pdf
Mu YM, Misra A, Adam JMF, et al. Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV
inhibitors. Diabetes Res Clin Pract 2012;95(2):179-88
Muhaya M. The eye in diabetes. Hosp Med 2003;64(11):673-6
24. Naing C, Mak JW, Wai N, et al. Diabetes and infections-hepatitis C: is there type 2 diabetes excess in
hepatitis C infection? Curr Diab Rep 2013;13(3):428-34
25. Ng CJ, Liew SM, Vethakkan SR, et al. Patient‐adjusted versus health professional‐adjusted insulin dosing
for type 2 diabetes mellitus. The Cochrane Library 2013;(6)
26. Nik Ritza Kosai, Nik Mahmood. Is bariatic surgery the cure for diabetes mellitus? Medicine & health
2013;8(2):52-4
http://www.medicineandhealthukm.com/system/files/article/2014/Editorial.pdf
27. Ong HT, Cheah JS. Choice of antihypertensive drug in the diabetic patient. MedGenMed 2005;7(2):74
http://www.medscape.org/viewarticle/502546
28. Ooi CP, Loke SC. Colesevelam for type 2 diabetes mellitus: an abridged Cochrane review. Diabet Med
2014;31(1):2-14
http://onlinelibrary.wiley.com/doi/10.1111/dme.12295/pdf
29. Ooi CP, Loke SC. Sweet potato for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013;9:CD009128
30. Ooi CP, Loke SC. Colesevelam for type 2 diabetes mellitus. Cochrane Database Syst Rev 2012;12:CD009361
31. Ooi CP, Zaitun Y, Tengku Aizan H. Momordica charantia for type 2 diabetes mellitus. Cochrane Database
Syst Rev 2012;8:CD007845
32. Ramadas A, Quek KF, Chan CK, et al. Web-based interventions for the management of type 2 diabetes
mellitus: a systematic review of recent evidence. Int J Med Inform 2011;80(6):389-405
http://www.ijmijournal.com/article/S1386-5056%2811%2900047-5/pdf
33. Sayeeda R, Tahminur R, Aziz Al-Shafi I, et al. Diabetes-associated macrovasculopathy: pathophysiology
and pathogenesis. Diabetes Obes Metab 2007;9(6):767-80
34. Sazlina SG, Browning C, Mohd Shajahan MY. Interventions to promote physical activity in older people
with type 2 diabetes mellitus: a systematic review. Front Public Health 2013;1:71
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870318/pdf/fpubh-01-00071.pdf
35. Shafie O, Fatanah I, Noor Azah D. Diabetes program in Malaysia - current and future. NCD Malaysia
2004;3(2):6-12
36. Sheu WHH, Azhari R, Mithal A, et al. Addressing the burden of type 2 diabetes and cardiovascular disease
through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert
recommendations. Diabetes Res Clin Pract 2011;92(3):312-21
37. Subramanian K, Sekaran M, Qvist R, et al. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a
review. J Clin Biochem Nutr 2009;45(1):1-8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704321/pdf/jcbn-45-1.pdf
38. Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: the global scenario.
PLoS One 2013;8(11):e80436
http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.008043
6&representation=PDF
39. Velayudhan M. Managing diabetes during the Muslim fasting month of Ramadan. Med J Malaysia
2012;67(3):353,4; quiz 355
http://www.e-mjm.org/2012/v67n3/Diabetes.pdf
40. Wong RSY. Extrinsic factors involved in the differentiation of stem cells into insulin-producing cells: an
overview. Exp Diabetes Res 2011;2011:406182
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124109
41. Wong TW. Design of oral insulin delivery systems. J Drug Target 2010;18(2):79-92
42. Wong TW. Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul
2009;3(1):8-25
43. Yogarabindranath SN. Influence of diabetes mellitus and risk factors in activating latent tuberculosis
infection: a case for targeted screening in Malaysia. Med J Malaysia 2012;67(5):467-72
http://www.e-mjm.org/2012/v67n5/latent-tuberculosis-infection.pdf
44. Zainal Ariff AR, Hamimah H, Bunyarit SS. Clinical patterns of oro-facial infections. Annals of Dentistry
University of Malaya 2005;12(1):18-23
http://ejum.fsktm.um.edu.my/ArticleInformation.aspx?ArticleID=372
45. Zanariah H, Hamdy O, Chia YC, et al. Transcultural Diabetes Nutrition Algorithm: A Malaysian Application.
Int J Endocrinol 2013;2013:679396
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872099
46. Zar CT, Das S. Potential effect of herbs on diabetic hypertension: alternative medicine treatment
modalities. Clin Ter 2013;164(6):529-35
Original research
VARIOUS SETTINGS, EXCEPT PRIMARY CARE
1. Abdul Hamid J, Azmi MT. Predictors of survival among end stage renal failure patients undergoing dialysis
treatment in Pahang from 2000 TO 2004. Jurnal Kesihatan Masyarakat 2009;15(1):76-84
http://journalarticle.ukm.my/4626/1/Vol15(1)-azimatun.pdf
2. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties of the Malay version of the
Osteoporosis Health Belief Scale (OHBS-M) among type 2 diabetic patients. Int J Rheum Dis 2014;17(1):93105
3. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties and osteoprotective
behaviors among type 2 diabetic patients: osteoporosis self-efficacy scale Malay version (OSES-M).
Osteoporos Int 2013;24(3):929-40
4. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties of Osteoporosis Knowledge
Tool and self-management behaviours among Malaysian type 2 diabetic patients. J Community Health
2013;38(1):95-105
5. Abougalambou SSI, Abougalambou ASI. A study evaluating prevalence of hypertension and risk factors
affecting on blood pressure control among type 2 diabetes patients attending teaching hospital in
Malaysia. Diabetes Metab Syndr 2013;7(2):83-6
6. Abougalambou SSI, Abougalambou ASI, Syed Azhar SS, et al. Prevalence of hypertension, control of blood
pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia.
Diabetes Metab Syndr 2011;5(3):115-9
7. Abougalambou SSI, Mohd Azmi AH, Syed Azhar SS, et al. Prevalence of vascular complications among type
2 diabetes mellitus outpatients at teaching hospital in Malaysia. Journal of Diabetes & Metabolism
2011;2(1):1000115
http://omicsonline.org/2155-6156/2155-6156-2-115.pdf
8. Abougalambou SSI, Mafauzy M, Syed Azhar SS, et al. Current clinical status and complications among type
2 diabetic patients in Universiti Sains Malaysia hospital. International Journal of Diabetes Mellitus
2010;2(3):184-8
9. Abougalambou SSI, Syed Azhar SS, Syed Wasif G, et al. Evaluation of direct medical cost among
outpatients of type 2 diabetes mellitus: cost analysis in teaching hospital of Malaysia. Folia Medica
Facultatis Medicinae Universitatis Saraeviensis (Journal of Medical Faculty University of Sarajevo, Bosnia &
Herzegovina) 2010;45(1):3-8
http://mf.unsa.ba/podaci/folia/Folia%20medica%2045-1.pdf
10. Adibah Hanim I, Rawa B, Hatta S, et al. Factor analysis study on sexual responses in women with type 2
diabetes mellitus. Compr Psychiatry 2014;55 Suppl 1:S34-7
11. Adibah Hanim I, Rawa B, Hatta S, et al. Orgasmic dysfunction among Malay diabetic women in Malaysia.
Compr Psychiatry 2014;55 Suppl 1:S29-33
12. Agarwal R, Siti Amrah S, Mafauzy M. Open label clinical trial to study adverse effects and tolerance to dry
powder of the aerial part of andrographis paniculata in patients type 2 with diabetes mellitus. Malays J
Med Sci 2005;12(1):13-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349408
13. Albaroodi KAI, Syed Sulaiman SA, Awaisu A. Evaluation of the most commonly used anti-diabetic drugs at
a hospital in northern part of Peninsular Malaysia. International Journal of Medical and Pharmaceutical
Sciences 2013;3(6). http://www.scopemed.org/fulltextpdf.php?mno=34156
14. Al-Hamodi Z, Saif-Ali R, Ikram Shah I, et al. Effect of plasminogen activator inhibitor-1 and tissue
plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects. J Biomed
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
Biotechnol 2012;2012:234937
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336151
Al-Hamodi Z, Ikram Shah I, Saif-Ali R, et al. Association of plasminogen activator inhibitor-1 and tissue
plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovasc
Diabetol 2011;10:23,2840-10-23
http://www.cardiab.com/content/pdf/1475-2840-10-23.pdf.
Al-Hamodi ZH, Saif-Ali R, Ikram Shah I, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism is
associated with metabolic syndrome parameters in Malaysian subjects. J Clin Biochem Nutr
2012;50(3):184-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334369
Ali RM, Degenhardt R, Robaayah Z, et al. Paclitaxel-eluting balloon angioplasty and cobalt-chromium
stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary
artery stenoses in patients with diabetes mellitus. EuroIntervention 2011;7 Suppl K:K83-92
Al-Maweri SAA, Noorliza Mastura I, Abdul Rashid I, et al. Prevalence of oral mucosal lesions in patients
with type 2 diabetes attending Hospital Universiti Sains Malaysia. Malays J Med Sci 2013;20(4):39-46
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773351
Al-Qazaz HK, Mohd Azmi AH, Asrul Akmal S, et al. Perception and knowledge of patients with type 2
diabetes in Malaysia about their disease and medication: a qualitative study. Res Social Adm Pharm
2011;7(2):180-91
Al-Qazaz HK, Sulaiman SA, Mohd Azmi AH, et al. Diabetes knowledge, medication adherence and glycemic
control among patients with type 2 diabetes. Int J Clin Pharm 2011;33(6):1028-35
http://www.researchgate.net/publication/51798593_Diabetes_knowledge_medication_adherence_and_
glycemic_control_among_patients_with_type_2_diabetes/file/79e41504b611ebef28.pdf.
Al-Qazaz HK, Mohd Azmi AH, Asrul Akmal S, et al. The 14-item Michigan Diabetes Knowledge Test:
translation and validation study of the Malaysian version. Practical Diabetes International 2010;27(6):23841
http://www.thecochranelibrary.com/userfiles/espdi/file/238_241_PDI_JA.pdf.
Al-Qazaz HK, Mohd Azmi AH, Asrul AS, et al. The eight-item Morisky Medication Adherence Scale MMAS:
translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010;90(2):216-21
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109726
Amudha K, Choy AM, Mohamed R. M, et al. Short-term effect of atorvastatin on endothelial function in
healthy offspring of parents with type 2 diabetes mellitus. Cardiovasc Ther 2008;26(4):253-61
Amudha K, Chee KH, Tan KS, et al. Prevalence of peripheral artery disease in urban high-risk Malaysian
patients. Int J Clin Pract 2003;57(5):369-72
Annemans L, Demarteau N, Hu S, et al. An Asian regional analysis of cost-effectiveness of early irbesartan
treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in
patients with type 2 diabetes, hypertension, and nephropathy. Value Health 2008;11(3):354-64
Aravind SR, Shaiful Bahari I, Balamurugan R, et al. Hypoglycemia in patients with type 2 diabetes from
India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic
study. Curr Med Res Opin 2012;28(8):1289-96
Aravind SR, Al Tayeb K, Shaiful Bahari I, et al. Hypoglycaemia in sulphonylurea-treated subjects with type 2
diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin
2011;27(6):1237-42
Asma A, Azmi MN, Mazita A, et al. A single blinded randomized controlled study of the effect of
conventional oral hypoglycemic agents versus intensive short-term insulin therapy on pure tone
audiometry in type II diabetes mellitus. Indian J Otolaryngol Head Neck Surg 2011;63(2):114-8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102159/pdf/12070_2011_Article_132.pdf
Assila AH, Seak YS, Goh ZP, et al. What contributes to the progression of chronic kidney disease in type 2
diabetic patients? International Journal of Public Health Research 2011;1(1):40-7
http://journalarticle.ukm.my/3343/1/vol%25201%2520no%25201%25202011_6.pdf
Aswany N, Ismail AA, Wan Mohamad WB, et al. Effect of Ramadan fasting on glycemic status of type 2
diabetic patients in Northern Malaysia. International Medical Journal (IIUM) 2003;2(2).
31. Aye M, Malek S. Waist circumference and BMI cut-off points to predict risk factors for metabolic
syndrome among outpatients in a district hospital. Singapore Med J 2012;53(8):545-50
http://www.sma.org.sg/UploadedImg/files/SMJ/5308/5308a8.pdf
32. Azarisman Shah MS, Aszrin A, Marzuki AO, et al. Blood pressure control among diabetic hypertensives
under cardiology follow-up at a regional hospital in rural Malaysia. Southeast Asian J Trop Med Public
Health 2010;41(4):973-81
33. Azidah AK, Hasniza H, Zunaina E. Prevalence of falls and its associated factors among elderly diabetes in a
tertiary center, Malaysia. Curr Gerontol Geriatr Res 2012;2012:539073
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369479
34. Azidah AK, Hasniza H. Prevalence of falls in elderly men with diabetes in Diabetic Clinic Universiti Sains
Malaysia Hospital, Malaysia. Journal of Men's Health 2011;8 Suppl 1:S91-3
35. Azizi A, Rafidah Hanim M, Tariq AR. Effects of irbesartan on beta-cell function and insulin sensitivity in
hypertensive and hypertensive diabetic subjects. International Medical Journal (IIUM) 2005;4(1).
36. Azura Dina M, Wong M, Norlela S, et al. Prevalence of sexual dysfunction among premenopausal women
with and without type 2 diabetes mellitus. Journal of Endocrinology and Metabolism 2013;3(1):29-39
http://www.jmems.org/index.php/jmems/article/view/75/59
37. Badariah A, Khalid AK, Quek KF, et al. Knowledge of diabetes and lifestyle behaviour amongst indigenous
population in Peninsular Malaysia. Med J Malaysia 2013;68(4):309-14
http://www.e-mjm.org/2013/v68n4/knowledge-of-diabetes.pdf
38. Badariah A, Ramadas A, Quek KF. The development and validation of diabetes knowledge questionnaire
for the Indigenous population in Malaysia. Med J Malaysia 2010;65(4):273-6
http://www.e-mjm.org/2010/v65n4/Diabetes_Knowledge.pdf
39. Barakatun Nisak MY, Ruzita AT, Norimah AK, et al. Improvement of dietary quality with the aid of a low
glycemic index diet in Asian patients with type 2 diabetes mellitus. J Am Coll Nutr 2010;29(3):161-70
40. Barakatun Nisak MY, Ruzita AT, Norimah AK, et al. Acute effect of low and high glycemic index meals on
post-prandial glycemia and insulin responses in patients with type 2 diabetes mellitus. Malaysian Journal
of Medicine and Health Sciences 2009;5(1):11-20
http://medic.upm.edu.my/images/stories/journal/VOL5NO1_JANUARY2009.pdf
41. Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of self-monitoring of blood glucose in the management
of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre,
randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab
2008;10(12):1239-47
https://www.cgsmedicare.com/jc/MDCorner/BGM/29.pdf
42. Bauman A, Phongsavan P, Schoeppe S, et al. Noncommunicable disease risk factors and socioeconomic
inequalities – what are the links? A multicountry analysis of noncommunicable disease surveillance data.
Report to the WHO Regional Office for the Western Pacific.
2010;http://www.wpro.who.int/publications/docs/WHOSESFINALforupload.pdf
43. Bawazir A, Gharebaghi R, Hussein A, et al. Non-arteritic anterior ischaemic optic neuropathy in Malaysia: a
5 years review. Int J Ophthalmol 2011;4(3):272-4
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340813/pdf/ijo-04-03-272.pdf
44. Biswas R, Maniam J, Lee EWH, et al. User-driven health care: answering multidimensional information
needs in individual patients utilizing post-EBM approaches: an operational model. J Eval Clin Pract
2008;14(5):750-60
45. Buranakitjaroen P, Mangklabruks A, Leungwattanakij S, et al. Efficacy and safety of sildenafil in Asian
males with erectile dysfunction and cardiovascular risk. J Med Assoc Thai 2007;90(6):1100-8
46. Chan C, Robaayah Z, Upendra K, et al. A randomized comparison of sirolimus‐eluting versus bare metal
stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study.
Catheterization and Cardiovascular Interventions 2008;72(5):591-600
47. Chan JCN, Wat NMS, So WY, et al. Renin angiotensin aldosterone system blockade and renal disease in
patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care
2004;27(4):874-9
http://care.diabetesjournals.org/content/27/4/874.full.pdf
48. Chan SP, Ji LN, Nitiyanant W, et al. Hypoglycemic symptoms in patients with type 2 diabetes in AsiaPacific-Real-life effectiveness and care patterns of diabetes management: the RECAP-DM study. Diabetes
Res Clin Pract 2010;89(2):e30-2
49. Chan HH, Zubaidah HAR, Jessie K, et al. Salivary proteins associated with periodontitis in patients with
type 2 diabetes mellitus. Int J Mol Sci 2012;13(4):4642-54
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344237/pdf/ijms-13-04642.pdf
50. Chan WK, Tan ATB, Vethakkan SR, et al. Non-alcoholic fatty liver disease in diabetics--prevalence and
predictive factors in a multiracial hospital clinic population in Malaysia. J Gastroenterol Hepatol
2013;28(8):1375-83
51. Chee EK, Kwan MK, Khoo EH. Necrotizing fasciitis of the lower limb - a prospective study of prognostic
factors affecting mortality. Malays Orthop J 2009;3(1):32-5
http://www.morthoj.org/2009v3n1/Necrotizing_Fasciitis_lower_limb.pdf.
52. Chia YC, Srinivas P. Cardiovascular disease risk in a semirural community in Malaysia. Asia Pac J Public
Health 2009;21(4):410-20
53. Chiam PTL, Abdullah F, Chow HK, et al. The ethnic characteristics and prevalence of diabetes mellitus,
hypertension and hyperlipidaemia in patients who underwent coronary artery bypass grafting in Hospital
Universiti Kebangsaan Malaysia. Med J Malaysia 2002;57(4):460-6
54. Chin KH, Sathyasurya DR, Hazizi AS, et al. Effect of ethnicity, dietary intake and physical activity on plasma
adiponectin concentrations among malaysian patients with type 2 diabetes mellitus. Int J Endocrinol
Metab 2013;11(3):167-74
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860115
55. Chin SP, Liew CK, Tay SP, et al. Platelet non-responsiveness to dual antiplatelet therapy and relation to
coronary disease among diabetes patients. Int J Cardiol 2007;118(3):418-20
56. Chin SP, Shahrin Tarmizi CA, How SH, et al. Do patients' understanding of diabetes and perception of
control predict higher HbA1c and complications? International Medical Journal (IIUM) 2006;5(1)
57. Chong VHT, Tan CT, Goh KJ, et al. Occupational exposure, age, diabetes mellitus and outcome of acute
Nipah encephalitis. Neurology Journal of Southeast Asia 2001;6:7-11
http://www.neurology-asia.org/articles/20011_007.pdf
58. Chong YB, Keng TC, Tan LP, et al. Clinical predictors of non-diabetic renal disease and role of renal biopsy
in diabetic patients with renal involvement: a single centre review. Ren Fail 2012;34(3):323-8
59. Choo KE, Lau KB, Davis WA, et al. Cardiovascular risk factors in pre-pubertal Malays: effects of diabetic
parentage. Diabetes Res Clin Pract 2007;76(1):119-25
60. Choo M, Prakash K, Amir S, et al. Corneal changes in type II diabetes mellitus in Malaysia. Int J Ophthalmol
2010;3(3):234-6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340640
61. Chuang LM, Soegondo S, Soewondo P, et al. Comparisons of the outcomes on control, type of
management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res
Clin Pract 2006;71(2):146-55
62. Chuang LM, Tsai ST, Huang BY, et al. The status of diabetes control in Asia--a cross-sectional survey of 24
317 patients with diabetes mellitus in 1998. Diabet Med 2002;19(12):978-85
63. Cliffton A, Md. Mizanur R, Mohd Syafiq A. The relevant intervention strategies for improving medication
adherence of diabetic patients. International Journal of Public Health Research 2013;3(1):236
http://journalarticle.ukm.my/6132/1/vol_3_no_1_2013_31.pdf
64. Dhanjal TS, Lal M, Haynes R, et al. A comparison of cardiovascular risk factors among Indo-Asian and
caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham,
England. Int J Clin Pract 2001;55(10):665-8
65. Duong JK, Kumar SS, Kirkpatrick CM, et al. Population pharmacokinetics of metformin in healthy subjects
and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin
Pharmacokinet 2013;52(5):373-84
66. Eid M, Mafauzy M, Faridah AR. Non-achievement of clinical targets in patients with type 2 diabetes
mellitus. Med J Malaysia 2004;59(2):177-84
http://www.e-mjm.org/2004/v59n2/Type_2_Diabetes_Mellitus.pdf
67. Eid M, Mafauzy M, Faridah AR. Dyslipidaemic pattern of patients with type 2 diabetes mellitus. Malays J
Med Sci 2004;11(1):44-51
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438150
68. Eid M, Mafauzy M, Faridah A. Glycaemic control of type 2 diabetic patients on follow up at hospital
universiti sains malaysia. Malays J Med Sci 2003;10(2):40-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561886
69. Eid M, Mafauzy M, Faridah AR. Dyslipidaemia In patients with type 2 diabetes mellitus. Journal of the
ASEAN Federation of Endocrine Societies 2003;21(1/2):44-54.
70. Elfatih IE, Abdul Razak M, Mohamed Izham MI, et al. A survey of tuberculosis cases in Penang Hospital:
preliminary findings. Malaysian Journal of Pharmaceutical Sciences 2004;2(2):1-8
http://myais.fsktm.um.edu.my/6805/1/a_survey_vol2_no2_(1-8)2004.PDF;
http://www.pha.usm.my/pharmacy/Webpage%20journal/abstract/2.2-1.pdf
71. Eppens MC, Craig ME, Jones TW, et al. Type 2 diabetes in youth from the Western Pacific region:
glycaemic control, diabetes care and complications. Curr Med Res Opin 2006;22(5):1013-20
72. ESRD Incidence Study Group, Stewart JH, McCredie MR, et al. Geographic, ethnic, age-related and
temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific
region, 1998-2002. Nephrol Dial Transplant 2006;21(8):2178-83
73. Etemad A, Ramachandran V, Pishva SR, et al. Analysis of Gln223Agr polymorphism of Leptin Receptor
Gene in type II diabetic mellitus subjects among Malaysians. Int J Mol Sci 2013;14(9):19230-44
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794830
74. Foo SH, Chan SP, Shaiful Bahari I, et al. Insulin resistance is the predominant pathophysiologic feature of
hyperglycemia in newly diagnosed overweight and obese type 2 diabetes mellitus in two university
hospitals in Malaysia. Journal of the ASEAN Federation of Endocrine Societies 2012;26(2):143-9
http://www.asean-endocrinejournal.org/images/ISSUE2/oa-insulin%20resistance%20-%20malaysia.pdf
75. Foo SM, Wong HS, Zaki Morad MZ. Risk factors and incidence of posttransplant diabetes mellitus in renal
transplant recipients. Transplant Proc 2004;36(7):2139-40
76. Fuziah MZ, Hong JY, Zanariah H, et al. A national database on children and adolescent with diabetes (eDiCARE): results from April 2006 to June 2007. Med J Malaysia 2008;63 Suppl C:37-40
77. G. R. Letchuman R, Wan Nazaimoon WM, Wan Mohamad WB, et al. Prevalence of diabetes in the
Malaysian National Health Morbidity Survey III 2006. Med J Malaysia 2010;65(3):180-6
http://www.e-mjm.org/2010/v65n3/Diabetes.pdf
78. Ghani RA, Bin Yaakob I, Wahab NA, et al. The influence of fenofibrate on lipid profile, endothelial
dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed
dyslipidemia. J Clin Lipidol 2013;7(5):446-53
79. Gillani SW, Syed Azhar SS, Sari YO, et al. Perceived Stress Scale psychometric validation for Malaysian
diabetic patients. British Journal of Pharmaceutical Research 2011;1(4):156-63
http://zenodo.org/record/8643/files/1319340970-WasifSayed_2011BJPR511.pdf
80. Gillani SW, Syed Azhar SS, Suzana CV, et al. Applicability of pharmaceutical care in endocrine clinic of
Hospital Penang, Malaysia. Journal of Diabetes Research and Clinical Metabolism 2012;1(1):11
http://www.hoajonline.com/journals/pdf/2050-0866-1-11.pdf
81. Go KW, Teo SM, Hasniza AH. Efficacy and safety of oral hypoglycaemic agents in the treatment of diabetes
mellitus in patients with end stage renal failure on dialysis. Medical Practice Hospital Ipoh 2003;6(2):5-8
82. Goldhaber-Fiebert JD, Li H, Ratanawijitrasin S, et al. Inpatient treatment of diabetic patients in Asia:
evidence from India, China, Thailand and Malaysia. Diabet Med 2010;27(1):101-8
83. Hamidon B, Nabil I, Raymond AA. Risk factors and outcome of dysphagia after an acute ischaemic stroke.
Med J Malaysia 2006;61(5):553-7
http://www.e-mjm.org/2006/v61n5/Acute_Ischaemic_Stroke.pdf
84. Hamidon B, Raymond AA. The impact of diabetes mellitus on in-hospital stroke mortality. J Postgrad Med
2003;49(4):307,9; discussion 309-10
85. Hamidon B, Raymond AA. Predictors of in-hospital mortality after an acute ischaemic stroke. Neurology
Journal of Southeast Asia 2003;8:5-8
http://www.neurology-asia.org/articles/20031_005.pdf
86. Hanifullah K. A call to arms – clear the confusion. Journal of Endocrinology and Metabolism 2013;3(1):24-8
http://www.jmems.org/index.php/jmems/article/view/74/58
87. Hapizah MN, Musilawati M, Yeo CK, et al. Type of diabetes and waist-hip ratio are important determinants
of serum lipoprotein (a) levels in diabetic patients. Diabetes Res Clin Pract 2002;56(3):221-7
88. Hasan SS, Syed Imran A, Nadeem Irfan B, et al. Use of complementary and alternative medicine among
patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 2009;15(3):152-7
89. Hasan SS, Ahmadi K, Santigo R, et al. The validity of the menopause-specific quality of life questionnaire in
women with type 2 diabetes. Climacteric 2013;.
90. Hasnan J, Mohd Imran Y, Damitri TD, et al. Relationship between apoptotic markers (Bax and Bcl-2) and
biochemical markers in type 2 diabetes mellitus. Singapore Med J 2010;51(1):50-5
http://smj.sma.org.sg/5101/5101a7.pdf
91. Hasniza ZH, Lee CL. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC
Public Health 2013;13:1192,2458-13-1192
http://www.biomedcentral.com/content/pdf/1471-2458-13-1192.pdf
92. Hasniza ZH, Wee HF. Drug related problems in type 2 diabetes patients with hypertension: a crosssectional retrospective study. BMC Endocr Disord 2013;13:2,6823-13-2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542270
93. Hasniza ZH, Yeap SM, Rokiah P. Episodes of hypoglycemia and hyperglycemia during the use of sliding
scale insulin in hospitalized diabetes patients. Asian Biomedicine 2007;1(3):307-11
http://abm.digitaljournals.org/index.php/abm/article/viewFile/133/52
94. Hasniza ZH, Tan G,Kuan Foong, Rokiah P, et al. Different characteristics of diabetic ketoacidosis between
type 1 and type 2 diabetes patients in Malaysia. Asian Biomedicine 2009;3(2):201-5
http://abm.digitaljournals.org/index.php/abm/article/viewFile/446/327
95. Hasniza ZH, Ong CW, Rokiah P. Self-monitoring of blood glucose among type-2 diabetes patients in
Malaysia. Asian Biomedicine 2008;2(4):335-40
http://abm.digitaljournals.org/index.php/abm/article/viewFile/198/117
96. Hassan SA, Rahman RA, Huda N, et al. Hospital-acquired Clostridium difficile infection among patients
with type 2 diabetes mellitus in acute medical wards. J R Coll Physicians Edinb 2013;43(2):103-7
97. Hayati AR, Cheah FC, Tan AE, et al. Insulin-like growth factor-1 receptor expression in the placentae of
diabetic and normal pregnancies. Early Hum Dev 2007;83(1):41-6
98. Hayati AR, Cheah FC, Yong JF, et al. The role of serum insulin-like growth factor I (IGF-I) in neonatal
outcome. J Clin Pathol 2004;57(12):1299-301
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770509
99. Hazizi AS, Zaitun MY, Mirnalini K, et al. Glycaemic control, lipid profile, blood pressure and body weight
status among diabetics in rural Malaysia. International Medical Journal (IIUM) 2007;8(2):21-8
http://iiumedic.net/imjm/v1/download/Volume%2008%20No%202/IMJVol8No2pg21-28.pdf
100. Hidayah NI, Che Muhaya M, Hanizah Y, et al. Risk factors for low vision amongst individuals aged 40 years
and above in the subdistrict of Beranang, Hulu Langat, Selangor. International Medical Research Journal
2001;5(1):13-6
101. Home PD, Latif ZA, Gonzalez-Galvez G, et al. The effectiveness and safety of beginning insulin aspart
together with basal insulin in people with type 2 diabetes in non-Western nations: results from the
A(1)chieve observational study. Diabetes Res Clin Pract 2013;101(3):326-32
http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(13)00231-3/pdf
102. Ibrahim SS, baougalambou ASI, Rahmawati F, et al. Prevalence and control of hypertension among
diabetes patients in Hospital Universiti Sains Malaysia, Malaysia. Majalah Farmasi Indonesia
2010;21(2):121-8
103. Ikram Shah I, Wan Nazaimoon WM, Wan Mohamad WB, et al. Ethnicity and glycaemic control are major
determinants of diabetic dyslipidaemia in Malaysia. Diabet Med 2001;18(6):501-8
http://umexpert.um.edu.my/file/publication/00000559_30514.pdf
104. Ikram Shah I, Wan Nazaimoon WM, Wan Mohamad WB, et al. Sociodemographic determinants of
glycaemic control in young diabetic patients in peninsular Malaysia. Diabetes Res Clin Pract 2000;47(1):5769
105. Indran M, Rokiah P, Chan SP, et al. Alteration of lipid peroxidation and antioxidant enzymes in young
Malaysian IDDM patients. Med J Malaysia 2004;59(2):166-70
http://www.e-mjm.org/2004/v59n2/Lipid_Peroxidation_Antioxidant_Enzymes.pdf.
106. Ismail MN, Chee WSS, Nawawi H, et al. Obesity in Malaysia. Obes Rev 2002;3(3):203-8
http://site.ppk.com.my/Clients/ppkcommy/obesity_and_metabolic_risk_in_asians.pdf
107. Jamsiah M, Zurainatul Irwani I, Sharifa Ezat WP, et al. Stress among diabetic mellitus patients with
complication at Raja Perempuan Zainab II Hospital, Kota Bharu, Kelantan. Jurnal Kesihatan Masyarakat
2009;15(1):39-46
http://journalarticle.ukm.my/4622/1/Vol15(1)-azimatun.pdf
108. Juwita S, Suraya M, Nor Azwany Y. Awareness of correct blood glucose target among type 2 diabetic
mellitus patient attending diabetic centre of tertiary hospital. International Journal of Collaborative
Research on Internal Medicine & Public Health 2012;4(12):1923-31
http://www.iomcworld.com/ijcrimph/files/v04-n12-07.pdf.
109. Kalra S, Plata-Que T, Kumar D, et al. Initiation with once-daily BIAsp 30 results in superior outcome
compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic
drugs. Diabetes Res Clin Pract 2010;88(3):282-8
110. Kamarul Imran M, Ismail AA, Naing L, et al. The reliability and validity of the Malay version of the 18-item
audit of Diabetes Dependent Quality of Life (the Malay ADDQOL) questionnaire. Southeast Asian J Trop
Med Public Health 2007;38(2):398-405
111. Kee CC, Yusoff hF, Sumarni MG, et al. Optimal BMI cut-off values for predicting diabetes, hypertension
and hypercholesterolaemia in a multi-ethnic population. Public Health Nutr 2013;16(3):453-9
http://journals.cambridge.org/download.php?file=%2FPHN%2FPHN16_03%2FS1368980012002911a.pdf&
code=49f9a158f8ba297da22b52fd9ff5084a.
112. Khaled AA, Sekaran M, Ikram Shah I. Role of N-(carboxymethyl)lysine in the development of ischemic
heart disease in type 2 diabetes mellitus. J Clin Biochem Nutr 2007;41(2):97-105
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2170948
113. Khalid AK, Wan Nazaimoon WN. The spread of diabetes mellitus in South-East Asia. Journal of the ASEAN
Federation of Endocrine Societies 2001;19(1):14-9
114. Koay CB, Mohd Zabri Affendi M, Moissinac K. Comparison of olfactory acuity in diabetic and non-diabetic
patients and using Alcohol Sniff Olfactory Test (ASOT) and University of Pennsylvania Smell Identification
Test (UPSIT). International Medical Research Journal 2000;4(1).
115. Koo H, Daniel Robert S, Hamid Jan JM. Which is a better anthropometric indicator of cardiovascular risk
factors in type 2 diabetes mellitus patients? Waist hip ratio or body mass index? Malays J Nutr
2013;19(2):163-72
http://nutriweb.org.my/publications/mjn0019_2/2%20Hamid%20_418(edSP)(RV)SP.pdf
116. Kulenthran A, Abdul Majeed N. Glycated haemoglobin is a good predictor of neonatal hypoglycaemia in
pregnancies complicated by diabetes. Malays J Pathol 2011;33(1):21-4
http://www.mjpath.org.my/2011.1/Glycated_haemoglobin.pdf
117. Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to xanthine oxidase and antioxidant
indices in Malaysian type 2 diabetes patients. Diabet Med 2005;22(10):1343-6
118. Kuppusamy UR, Indran M, Tsara A, et al. Comparison of oxidative damage in Malaysian end-stage renal
disease patients with or without non-insulin-dependent diabetes mellitus. Clin Chim Acta 2005;351(12):197-201
119. Lai PSM, Chua SS, Tan CH, et al. Validation of the diabetes, hypertension and hyperlipidemia (DHL)
knowledge instrument in Malaysia. BMC Med Res Methodol 2012;12:18,2288-12-18
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352255
120. Lai SY, Yahaya H, Noorizan AA, et al. A comparison of knowledge of diabetes mellitus between patients
with diabetes and healthy adults: a survey from north Malaysia. Patient Educ Couns 2007;69(1-3):47-54
121. Lai LC. Prevention of type 2 diabetes. Malays J Pathol 2002;24(2):71-6
http://www.mjpath.org.my/past_issue/MJP2002.2/Prevention%20of%20type%202%20Diabetes.pdf
122. Latiffah AL, Nor Afiah MZ, Nor Amalina E, et al. Prevalence of diseases among elderly admitted to a
tertiary hospital in Malaysia 2002. International Medical Journal (IIUM) 2006;5(1).
123. Lau CH, Sekaran M. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful
integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case
control study. Cardiovasc Diabetol 2011;10(1):8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036610/pdf
124. Lee PY, Lee YK, Khoo EM, et al. How do health care professionals assess patients when initiating insulin
therapy? A qualitative study. Prim Care Diabetes 2014;8(1):49-55
125. Lee YK, Lee PY, Ng CJ. Tactics in counselling patients to start insulin. Diabet Med 2013;30(3):373-4
126. Lee YK, Low WY, Ng CJ. Exploring patient values in medical decision making: a qualitative study. PLoS One
2013;8(11):e80051
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839918
127. Lee YY, Tee MH, Zurkurnai Y, et al. Thrombolytic failure with streptokinase in acute myocardial infarction
using electrocardiogram criteria. Singapore Med J 2008;49(4):304-10
http://smj.sma.org.sg/4904/4904a5.pdf
128. Lee YK, Low WY, Lee PY, et al. Factors influencing decision-making role preferences: A qualitative study of
Malaysian patients with type 2 diabetes during insulin initiation. Int J Nurs Pract 2014
129. Li YY, Wang XM, Lu XZ. KCNQ1 rs2237892 C-->T gene polymorphism and type 2 diabetes mellitus in the
Asian population: a meta-analysis of 15,736 patients. J Cell Mol Med 2014;18(2):274-82
130. Lim TO, Rugayah B, Maimunah AH. Familial aggregation and determinants of post challenge blood glucose
in four ethnic populations. Med J Malaysia 2004;59(3):357-71
http://www.e-mjm.org/2004/v59n3/Familial_Aggregation.pdf
131. Lim TO, Rugayah B, Zaki Morad MZ, et al. Bimodality in blood glucose distribution: is it universal? Diabetes
Care 2002;25(12):2212-7
http://care.diabetesjournals.org/content/25/12/2212.full.pdf+html
132. Lim TO, Ding LM, Zaki Morad MZ, et al. Clustering of hypertension, abnormal glucose tolerance,
hypercholesterolaemia and obesity in Malaysian adult population. Med J Malaysia 2000;55(2):196-208
http://www.e-mjm.org/2000/v55n2/Hypertension.pdf
133. Lim PC, Lim SL, Oiyammaal C. Glycaemic control and cost analysis when changing from gliclazide coadministered with metformin to pre-combined glibenclamide-metformin tablets in type 2 diabetes
mellitus. Med J Malaysia 2012;67(1):21-4
http://www.e-mjm.org/2012/v67n1/Glibenclamide-Metformin.pdf
134. Lim SL, Soh KP, Kuppusamy UR. Effects of naringenin on lipogenesis, lipolysis and glucose uptake in rat
adipocyte primary culture: a natural antidiabetic agent. Internet Journal of Alternative Medicine 2008;5(2).
https://ispub.com/IJAM/5/2/11973
135. Lim-Abrahan MA, Jain AB, Wan Mohamad WB, et al. Safety and effectiveness of biphasic insulin aspart 30
in type 2 diabetes: results from the ASEAN cohort of the A(1)chieve study. Diabetes Res Clin Pract
2013;100 Suppl 1:S3-9
136. Linjawi S, Radhakrishna S, Sari R, et al. The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp
30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes
uncontrolled on sitagliptin and metformin-The Sit2Mix trial. Prim Care Diabetes 2014
137. Lock LT, Tzanakakis ES. Scalable production of pancreatic islet progenitors for diabetes cell therapies. Med
J Malaysia 2008;63 Suppl A:5-6
138. Loh BI, Sathyasuryan DR, Hamid Jan JM. Plasma adiponectin concentrations are associated with dietary
glycemic index in Malaysian patients with type 2 diabetes. Asia Pac J Clin Nutr 2013;22(2):241-8
http://apjcn.nhri.org.tw/server/APJCN/22/2/241.pdf
139. Loke SC, Rahim KF, Kanesvaran R, et al. A prospective cohort study on the effect of various risk factors on
hypoglycaemia in diabetics who fast during Ramadan. Med J Malaysia 2010;65(1):3-6
http://www.e-mjm.org/2010/v65n1/Hypoglycaemia_in_Diabetics.pdf
140. Loke SC, Jong M. Metabolic control in type 2 diabetes correlates weakly with patient adherence to oral
hypoglycaemic treatment. Ann Acad Med Singapore 2008;37(1):15-20
.
141. Loo KW, Griffiths LR, Gan SH. A sweet promise among Malaysians: Diabetes in Malaysia. J Diabetes 2014;.
142. Mafauzy M, Zanariah H, Chan SP. The status of diabetes control in Malaysia: results of DiabCare 2008.
Med J Malaysia 2011;66(3):175-81
http://www.e-mjm.org/2011/v66n3/Diabetes_Control.pdf
143. Mafauzy M, Diabcare-Asia 2003 Study Group. An audit on diabetes management in Asian patients treated
by specialists: the Diabcare-Asia 1998 and 2003 studies. Curr Med Res Opin 2008;24(2):507-14
144. Mafauzy M. Diabetes control and complications in public hospitals in Malaysia. Med J Malaysia
2006;61(4):477-83
http://www.e-mjm.org/2006/v61n4/Diabetes_Control_Complications.pdf
145. Mafauzy M, Winn T, Rampal L, et al. A prelimenary result of the cardiovascular risk factors intervention
study (Pikom Study): diabetes mellitus, hypertension and their associated factors. Malays J Med Sci
2005;12(1):20-5
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349409
146. Mafauzy M, Mokhtar N, Wan Mohamad WB. Hypertension and associated cardiovascular risk factors in
Kelantan. Med J Malaysia 2003;58(4):556-64
http://www.e-mjm.org/2003/v58n4/Hypertension.pdf
147. Mafauzy M. Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.
Diabetes Res Clin Pract 2002;58(1):45-53
148. Marre M, Shaw J, Brandle M, et al. Liraglutide, a once-daily human GLP-1 analogue, added to a
sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared
with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU). Diabet Med
2009;26(3):268-78
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871176
149. Mastura I, Zanariah H, Fatanah I, et al. An Audit of Diabetes Control and Management (ADCM). Med J
Malaysia 2008;63 Suppl C:76-7
150. Mastura I. Core competencies in diabetes care: educating health professionals as diabetes educators. NCD
Malaysia 2005;4(2):2-3
151. Md Yazid J, Fuziah MZ, Hadhrami M, et al. Reliability and validity of the Malay translated version of
diabetes quality of life for youth questionnaire. Malaysian Family Physician 2013;8(1):12-9
http://www.e-mfp.org/2013v8n1/diabetes-quality-of-life.pdf
152. Md Yazid J, Fuziah MZ, Hong JYH, et al. Reliability and validity of the revised summary of diabetes self-care
activities (SDSCA) for Malaysian children and adolescents. Malaysian Family Physician 2012;7(2&3):10-20
http://www.e-mfp.org/old/2012v7n2_3/Diabetes-Self-Care-Activities.pdf
153. Minas H, Ruzanna ZZ, Marhani M, et al. Attitudes of Malaysian general hospital staff towards patients
with mental illness and diabetes. BMC Public Health 2011;11:317,2458-11-317
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112131
154. Mohamed EAH, Mohammad Jamshed AS, Ang LF, et al. Potent alpha-glucosidase and alpha-amylase
inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus
Benth as anti-diabetic mechanism. BMC Complement Altern Med 2012;12:176,6882-12-176
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533584/pdf/1472-6882-12-176.pdf
155. Mohammad Yousuf R, Humairah-Cheung AS. A diabetic patient with sudden periorbital swelling and
proptosis. International Medical Journal (IIUM) 2003;2(2).
156. Mohammad Yousuf R, Fauzi ARM, How SH, et al. Metabolic changes during Ramadan fasting in normal
people and diabetic patients. International Medical Journal (IIUM) 2003;2(2).
157. Mohd Amin Bujang, Puzziawati Abdul Ghani, Nur Amirah Zolkepali, Sharmini Selvarajah and Jamaiyah
Haniff. A comparison between convenience sampling versus systematic sampling in getting the true
parameter in a population: Explore from a clinical database: The Audit Diabetes Control Management
(ADCM) registry in 2009International Conference on Statistics in Science, Business, and Engineering
(ICSSBE) 2012201210-12 Sept;LangkawiIEEE;2012.
158. Moy FM, Awang Bulgiba AM. The modified NCEP ATP III criteria maybe better than the IDF criteria in
diagnosing Metabolic Syndrome among Malays in Kuala Lumpur. BMC Public Health 2010;10:678,245810-678
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989964
159. Moy FM, Hoe VCW, Tan CPL, et al. Cardiovascular risks among shift and non-shift workers in a public
medical centre in Kuala Lumpur. JUMMEC 2010;13(1):45-9
http://jummec.um.edu.my/filebank/published_article/3155/JUMMEC%202010%2013(1)%2045-49.pdf
160. Moy FM, Atiya AS, Wong ML. The results of a worksite health promotion programme in Kuala Lumpur,
Malaysia. Health Promot Int 2006;21(4):301-10
http://heapro.oxfordjournals.org/content/21/4/301.full.pdf
161. Muhammad RA H, Subhada PP, Ng PP, et al. Incidence, risk factors and clinical epidemiology of
melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah,
Malaysia. BMC Infect Dis 2010;10:302,2334-10-302
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975659
162. Muhammad K, Al-Jamal HAN, Narazah MY. Association of ABO blood groups with diabetes mellitus. Libyan
J Med 2010;5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071167
163. Nadzimah MN, Thevarajah M, Chew YY. Hemoglobin variants detected by hemoglobin A1c (HbA1c)
analysis and the effects on HbA1c measurements. Int J Diabetes Dev Ctries 2010;30(2):86-90
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878696
164. Naing C, Mak JW, Syed Imran A, et al. Relationship between hepatitis C virus infection and type 2 diabetes
mellitus: meta-analysis. World J Gastroenterol 2012;18(14):1642-51
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325531/pdf/WJG-18-1642.pdf.
165. Nawawi H, Sazali BS, Kamaruzaman BH, et al. Effect of ambient temperature on analytical and clinical
performance of a blood glucose monitoring system: Omnitest Sensor glucose meter. Ann Clin Biochem
2001;38(Pt 6):676-83
166. Nazratun N, Mahmood AA, Kuppusamy UR, et al. Diabetes mellitus exacerbates advanced glycation end
product accumulation in the veins of end-stage renal failure patients. Vasc Med 2006;11(4):245-50
167. Nazri M, Suhairi I, Wan Zaidah A, et al. Add-on rosiglitazone therapy improves plasminogen activity and
high-density lipoprotein cholesterol in type 2 diabetes mellitus. Blood Coagul Fibrinolysis 2011;22(6):51220
168. Ng SH, Chan KH, Lian ZY, et al. Reality vs illusion: Knowledge, attitude and practice among diabetic
patients. International Journal of Collaborative Research on Internal Medicine & Public Health
2012;4(5):723-32
http://www.iomcworld.com/ijcrimph/files/v04-n05-33.pdf
169. Ng TK. Prevalence of depression among diabetic patients in an outpatient clinic in Hospital Sik: A rural
hospital in Malaysia. Asian J Psychiatr 2010;3(2):76-7
170. Nirmala K, Hanis A, Izzat H, et al. Outcome of pregnancy among Malaysian women with diabetes mellitus a single centre experience. Malaysian Journal of Public Health Medicine 2013;13(2):1-10
http://www.mjphm.org.my/mjphm/journals/volume%2013%20(2)/OUTCOME%20OF%20PREGNANCY%20
AMONG%20MALAYSIAN%20WOMEN%20WITH%20DIABETES%20MELLITUS%20%20A%20SINGLE%20CENTRE%20EXPERIENCE.pdf
171. Nissapatorn V, Kuppusamy I, Josephine FP, et al. Tuberculosis: a resurgent disease in immunosuppressed
patients. Southeast Asian J Trop Med Public Health 2006;37 Suppl 3:153-60
http://www.tm.mahidol.ac.th/seameo/2006_37_spp3/37sup3_153.pdf
172. Nissapatorn V, Kuppusamy I, Sim BL, et al. Pulmonary tuberculosis in a hospital setting: gender
differences. Public Health 2006;120(5):441-3
173. Nissapatorn V, Kuppusamy I, Jamaiah I, et al. Tuberculosis in diabetic patients: a clinical perspective.
Southeast Asian J Trop Med Public Health 2005;36 Suppl 4:213-20
http://www.tm.mahidol.ac.th/seameo/2005_36_spp4/36sup4_213.pdf
174. Noor Hasimah M, Nurhanani M, Ramli M. Medical complications among type 2 diabetes mellitus patients
at a general hospital in east coast Malaysia. International Medical Journal (IIUM) 2010;9(1):15-20
http://iiumedic.net/imjm/v1/download/Volume%2009%20No%201/eIMJVol9No1_pg15-20.pdf
175. Nor Azwany Y, Abdul Aziz al-Safi I, Wan Mohamad WB. Knowledge, attitude, and practice of type 2
diabetes mellitus patients on Ramadan fasting at Hospital Universiti Sains Malaysia. Journal of the Islamic
Medical Association of North America 2007;39(1):6-12
http://jima.imana.org/article/view/5253/3609
176. Nor Hayati O, Anani Aila MZ. Association of colorectal carcinoma with metabolic diseases; experience with
138 cases from Kelantan, Malaysia. Asian Pac J Cancer Prev 2008;9(4):747-51
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/747%20c%20Othman.pdf
177. Nor Hayati O, Zaini MN, Biswal BM. Is Kelantan joining the global cancer epidemic?--experience from
hospital Universiti Sains Malaysia; 1987-2007. Asian Pac J Cancer Prev 2008;9(3):473-8
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No3/473%20Othman%20.pdf
178. Norbanee THT, Kamaliah MD, Ismail AA. Prevalence and risk factors for microalbuminuria in patients with
type 2 diabetes mellitus in north-east Malaysia. International Medical Journal (Tokyo) 2003;10:261-6
179. Norhafizah S, Siti Zuraidah M, Saari R, et al. Medication labeling literacy among Malaysian with diabetes: a
cross-sectional study. Journal of Diabetes Research and Clinical Metabolism 2012;1(1):23
http://www.hoajonline.com/journals/pdf/2050-0866-1-23.pdf
180. Norhayati Y, Kyi WM, Norhayati MN, et al. Type 2 diabetes with good glycemic control have improved
insulin response and lower non-esterified fatty acid level after a meal challenge. Journal of Diabetes
Mellitus 2012;2:1
http://www.scirp.org/journal/PaperDownload.aspx?FileName=JDM20120100025_14655500.pdf&paperID
=17284.
181. Norlaila M, Nor Azmi K, Abdul Aziz I, et al. Prevalence of abnormal glucose tolerance and risk factors in
urban and rural Malaysia. Diabetes Care 2011;34(6):1362-4
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114358
182. Norlaili M, Bakiah S, Zunaina E. Intravitreal triamcinolone versus laser photocoagulation as a primary
treatment for diabetic macular oedema--a comparative pilot study. BMC Ophthalmol 2011;11:36,2415-1136
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231950
183. Norlinah MI, Hamizah R, Siti Harnida MI, et al. The effects of short-term, rapid glycemic control on the
peroneal nerve function and serum VCAM-1 and AGE in type 2 diabetic patients in Malaysia. Indian J Med
Sci 2009;63(4):131-8
http://www.bioline.org.br/pdf?ms09027.
184. Ong HT. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. QJM
2005;98(8):599-614
http://qjmed.oxfordjournals.org/content/98/8/599.full.pdf.
185. Ong LM, Punithavathi N, Dharminy T, et al. Prevalence and risk factors for proteinuria: the National Kidney
Foundation of Malaysia Lifecheck Health Screening programme. Nephrology (Carlton) 2013;18(8):569-75
186. Ong MJ, Mohammadreza P, Tan CC, et al. Risk factors for clinically significant macular edema in a multiethnics population with type 2 diabetes. Int J Ophthalmol 2012;5(4):499-504
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428549
187. Ooi CG, Haizee HN, Kando DV, et al. Diabetes mellitus in a Malaysian teaching hospital: prevalence of
diabetes mellitus and frequency of testing for hypercholesterolaemia, proteinuria and HbA1c. Med J
Malaysia 2002;57(2):195-200
http://www.e-mjm.org/2002/v57n2/Diabetes_Mellitus.pdf
188. Oteh M, Shah Azarisman SM, Azreen SA, et al. Institutional hypertension control in Malaysia: a
multicenter study focusing on gender and cardiovascular risk factor profile difference. Hypertens Res
2011;34(3):319-24
189. Pan CY, So WY, Khalid AK, et al. Metabolic, immunological and clinical characteristics in newly diagnosed
Asian diabetes patients aged 12-40 years. Diabet Med 2004;21(9):1007-13
190. Pathak R, Pathak A. Study of life style habits on risk of type 2 diabetes. Int J Appl Basic Med Res
2012;2(2):92-6
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678701
191. Patil SS, Hasamnis AA, Narayan KA, et al. A household drug utilization survey among diabetics in rural
Malaysia. Int J Diabetes Dev Ctries 2010;30(4):231-2
http://www.rssdi.in/diabetesbulletin/2010/OCTOBER/IntJDiabDevCtries304231-8359286_021919.pdf
192. Pavai S, Chan SP. Urinary type IV collagen levels in diabetes mellitus. Malays J Pathol 2010;32(1):43-7
http://www.mjpath.org.my/2010.1/Urinary_type_IV_collagen.pdf
193. Poh R, Muniandy S. Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.
Southeast Asian J Trop Med Public Health 2010;41(5):1231-46
194. Poh R, Muniandy S. Ethnic variations in paraoxonase1 polymorphism in the Malaysian population.
Southeast Asian J Trop Med Public Health 2007;38(2):392-7
195. Purnami SW, Abdullah E, Jasni MZ, et al. A new smooth support vector machine and its applications in
diabetes disease diagnosis. Journal of Computer Science 2009;5(12):1003-8
http://thescipub.com/PDF/jcssp.2009.1003.1008.pdf
196. Puthucheary SD, Nathan SA. Comparison of serum F2 isoprostane levels in diabetic patients and diabetic
patients infected with Burkholderia pseudomallei. Singapore Med J 2008;49(2):117-20
http://smj.sma.org.sg/4902/4902a5.pdf
197. Qvist R, Ikram Shah I, Sekaran M, et al. Sialic acid and vascular cell adhesion molecule-1 as early markers
in the first degree relatives of type 2 diabetes meUitus patients. Journal of Medical Sciences
2006;6(2):235-40
http://198.170.104.138/jms/2006/235-240.pdf
198. Qvist R, Ikram Shah I, Muniandy S, et al. Plasma sialic acid levels in the offspring of one parent with type 2
diabetes mellitus. Biomedical Research 2005;16(3):213-7
http://www.biomedres.org/journal/pdf/114.pdf;http://eprints.um.edu.my/7225/1/plasma_sialic_acid_le
vels.pdf
199. Qvist R, Ismail IS, Karuthan C, et al. Use of glycated hemoglobin (HbA(1C)) and impaired glucose tolerance
in the screening of undiagnosed diabetes in the Malaysian population. Indian J Clin Biochem
2008;23(3):246-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3453455
200. Rafidah Hanim M, Azizi A, Noriah MN. Blood pressure variability in patients with diabetes mellitus. Asian
Cardiovasc Thorac Ann 2010;18(4):344-8
201. Rahmah MA, Noraishah J. Elderly diabetic patients’ perception on family support and glucose control.
International Journal of Public Health Research 2011;1(1):7
202. Rajakumar MK. Preventing diabetes: The task of the family doctor. Asia Pac Fam Med 2003;2(1):8-9
http://www.apfmj-archive.com/afm2.1/afm_027.pdf
203. Rajendra Acharya U, Faust O, Nahrizul Adib K, et al. Automated identification of normal and diabetes
heart rate signals using nonlinear measures. Comput Biol Med 2013;43(10):1523-9
204. Ramachandran V, Ismail P, Stanslas J, et al. Analysis of renin-angiotensin aldosterone system gene
polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects. Cardiovasc Diabetol
2009;8:11,2840-8-11
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656464
205. Ramachandran V, Ismail P, Stanslas J, et al. Association of insertion/deletion polymorphism of
angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in
Malaysian subjects. J Renin Angiotensin Aldosterone Syst 2008;9(4):208-14
http://jra.sagepub.com/content/9/4/208.long.
206. Ramadas A, Quek KF, Chan CK, et al. Randomised-controlled trial of a web-based dietary intervention for
patients with type 2 diabetes mellitus: study protocol of myDIDeA. BMC Public Health 2011;11:359,245811-359
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123593
207. Rampal S, Rampal L, Ramlee R, et al. Variation in the prevalence, awareness, and control of diabetes in a
multiethnic population: a nationwide population study in Malaysia. Asia Pac J Public Health
2010;22(2):194-202
208. Reddy SC, Tajunisah I, Low KP, et al. Prevalence of eye diseases and visual impairment in urban population
- A study from University of Malaya Medical Centre. Malaysian Family Physician 2008;3(1):25-8
http://www.e-mfp.org/old/2008v3n1/pdf/prevalence_eye_diseases.pdf
209. Renukanth PCR, Taiyeb-Ali TB, Chan SP, et al. Effect of nonsurgical periodontal therapy verses oral hygiene
instructions on type 2 diabetes subjects with chronic periodontitis: a randomised clinical trial. BMC Oral
Health 2014;14:79,6831-14-79
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082680
210. Reutens AT, Hutchinson R, Van Binh T, et al. The GIANT study, a cluster-randomised controlled trial of
efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care
practice. Diabetes Res Clin Pract 2012;98(1):38-45
211. Roach VJ, Hin LY, Tam WH, et al. The incidence of pregnancy-induced hypertension among patients with
carbohydrate intolerance. Hypertens Pregnancy 2000;19(2):183-9
212. Rokiah O, Knight VF, Zainora M. The causes of low vision and pattern of prescribing at UKM Low Vision
Clinic. Jurnal Sains Kesihatan Malaysia 2008;6(2):55-64
http://www.fskb.ukm.my/jurnal/jilid%206(2)2008/Chap%206.pdf
213. Roshana M, Azidah AK, Lili Husniati Y. A study on depression among patient with type 2 diabetes mellitus
in north-east coast Malaysia. International Journal of Collaborative Research on Internal Medicine & Public
Health 2012;4(8):1589-600
http://www.iomcworld.com/ijcrimph/files/v04-n08-10.pdf
214. Rothan HA, Suhaeb AM, Tunku Kamarul. Recombinant human adiponectin as a potential protein for
treating diabetic tendinopathy promotes tenocyte progenitor cells proliferation and tenogenic
differentiation in vitro. Int J Med Sci 2013;10(13):1899-906
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856381
215. Ruziana Mona, Wan Mohd Zin, Zati Iwani AK, Tuan Rosidah TS, et al. Haemoglobin A1c: comparing
performance of two point of care devices with laboratory analyser. BMC Res Notes 2013;6:540,0500-6540
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878320
216. Safiah Mokhtar S, M Vanhoutte P, W S Leung S, et al. Reduced expression of prostacyclin synthase and
nitric oxide synthase in subcutaneous arteries of type 2 diabetic patients. Tohoku J Exp Med
2013;231(3):217-22
217. Saif-Ali R, Harun R, Kamaruddin NA, et al. Association of hepatocyte nuclear factor 4 alpha polymorphisms
with type 2 diabetes with or without metabolic syndrome in Malaysia. Biochem Genet 2012;50(3-4):298308
218. Saif-Ali R, Ismail IS, Al-Hamodi Z, et al. KCNQ1 Haplotypes associate with type 2 diabetes in Malaysian
Chinese subjects. Int J Mol Sci 2011;12(9):5705-18
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189745
219. Saif-Ali R, Muniandy S, Al-Hamodi Z, et al. KCNQ1 variants associate with type 2 diabetes in Malaysian
Malay subjects. Ann Acad Med Singapore 2011;40(11):488-92
220. Saini R, Al-Maweri SA, Saini D, et al. Oral mucosal lesions in non oral habit diabetic patients and
association of diabetes mellitus with oral precancerous lesions. Diabetes Res Clin Pract 2010;89(3):320-6
221. Salem SD, Saif-Ali R, Ismail IS, et al. IGF2BP2 alternative variants associated with glutamic acid
decarboxylase antibodies negative diabetes in Malaysian subjects. PLoS One 2012;7(9):e45573
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446917
222. Salinatin MS, Mustaffa Halabi A, Adzrool Idzwan I. Diabetic healthcare awareness in Malaysia: the role of
poster as a communication medium. Procedia - Social and Behavioral Sciences 2013;91:539-44
http://www.sciencedirect.com/science/article/pii/S1877042813025834
223. Salmiah MA, Kamaruzaman J. Barriers to optimal control of type 2 diabetes in Malaysian Malay patients.
Glob J Health Sci 2009;1(2):106-18
http://www.ccsenet.org/journal/index.php/gjhs/article/view/3943/3479.
224. Sayeeda R, Aziz Al-Safi I, Shaiful Bahari I, et al. Early manifestation of macrovasculopathy in newly
diagnosed never treated type II diabetic patients with no traditional CVD risk factors. Diabetes Res Clin
Pract 2008;80(2):253-8
225. Sayeeda R, Aziz Al-Safi I, Shaiful Bahari I, et al. Effect of rosiglitazone/ramipril on preclinical vasculopathy
in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebocontrolled study. Eur J Clin Pharmacol 2007;63(8):733-41
226. Sazlina SG, Browning CJ, Mohd Shajahan MY. Promoting physical activity in sedentary elderly Malays with
type 2 diabetes: a protocol for randomised controlled trial. BMJ Open 2012;2(6):10.1136/bmjopen,2012002119. Print 2012
http://bmjopen.bmj.com/content/2/6/e002119.full.pdf
227. Shafie O, Zainal Ariffin O. Role of health promotion in management of cardiovascular diseases and
diabetes mellitus. NCD Malaysia 2003;2(2):2-5
228. Shahid HS, Kurdi MI, Zohair AA. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a
comparison between diabetic and non-diabetic patients with coronary artery disease. Med J Malaysia
2011;66(2):113-6
http://www.e-mjm.org/2011/v66n2/Coronary_Artery_Disease.pdf
229. Shaik MM, Gan SH, Kamal MA. Epigenomic approach in understanding Alzheimer's disease and type 2
diabetes mellitus. CNS Neurol Disord Drug Targets 2014;13(2):283-9.
230. Shareef BT, Ang KT, Naik VR. Qualitative and quantitative exfoliative cytology of normal oral mucosa in
type 2 diabetic patients. Med Oral Patol Oral Cir Bucal 2008;13(11):E693-6
http://www.medicinaoral.com/pubmed/medoralv13_i11_p693.pdf
231. Shariati NH, Zahedi E, Jajai HM. Classification of vascular function in upper limb using bilateral
photoplethysmographic signals. Physiol Meas 2008;29(3):365-74
232. Sharmilla T, Ahmad Hatim S, Jambunathan ST. Prevalence of obesity, lipid and glucose abnormalities in
outpatients prescribed clozapine in University Malaya Medical Center, Kuala Lumpur. Malaysian Journal
of Psychiatry 2008;17(2):37-46
http://www.mjpsychiatry.org/index.php/mjp/article/viewFile/38/38
233. Sharmini S, Uiterwaal CS, Jamaiyah H, et al. Renal impairment and all-cause mortality in cardiovascular
disease: effect modification by type 2 diabetes mellitus. Eur J Clin Invest 2013;43(2):198-207
234. Sharmini S, Fong AY, Selvaraj G, et al. An Asian validation of the TIMI risk score for ST-segment elevation
myocardial infarction. PLoS One 2012;7(7):e40249
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398026
235. Sheikh Anwar A, Azmi KN, Hamidon B, et al. An open label comparative study of glimepiride versus
repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. Med J Malaysia
2006;61(1):28-35
http://www.e-mjm.org/2006/v61n1/Type_2_Diabetes_Mellitus.pdf
236. Shen H, Qi L, Tai ES, et al. Uncoupling protein 2 promoter polymorphism -866G/A, central adiposity, and
metabolic syndrome in Asians. Obesity (Silver Spring) 2006;14(4):656-61
237. Sheu WHH, Ji LN, Nitiyanant W, et al. Hypoglycemia is associated with increased worry and lower quality
of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific
region. Diabetes Res Clin Pract 2012;96(2):141-8
238. Shubashini G, Ting KN, Wong KT, et al. Convergence of tuberculosis and diabetes mellitus: time to
individualise pharmaceutical care. Int J Clin Pharm 2011;33(1):44-52.
239. Siti Harnida MI, Najihah I, Nazaimoon WM, et al. Improvement in C-reactive protein and advanced
glycosylation end-products in poorly controlled diabetics is independent of glucose control. Diabetes Res
Clin Pract 2006;72(1):48-52.
240. Siti Khuzaimah AS, Wu VS. Self-efficacy and self-care behavior of Malaysian patients with type 2 diabetes:
a cross sectional survey. Nurs Health Sci 2012;14(1):38-45
http://onlinelibrary.wiley.com/doi/10.1111/j.1442-2018.2011.00658.x/pdf
241. Soewondo P, Mafauzy M, Jain AB, et al. Safety and effectiveness of insulin detemir in type 2 diabetes:
results from the ASEAN cohort of the A(1)chieve study. Diabetes Res Clin Pract 2013;100 Suppl 1:S10-6
242. Strojek K, Wan Mohamad WB, Khutsoane DT, et al. Once-daily initiation with biphasic insulin aspart 30
versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an openlabel, multinational RCT. Curr Med Res Opin 2009;25(12):2887-94
243. Sudha V, Bairy KL, Shashikiran U, et al. Efficacy and tolerability of Dianex in Type 2 diabetes mellitus: a non
randomized, open label non-comparative study. Med J Malaysia 2005;60(2):204-11
http://www.e-mjm.org/2005/v60n2/Type_2_Diabetes_Mellitus.pdf
244. Suehazlyn Z, Zaiton D, Masni M, et al. A Summary of the Malaysian Clinical Practice Guidelines:
Management of Type 2 Diabetes Mellitus (4th Edition) 2009. Journal of the ASEAN Federation of Endocrine
Societies 2012;26(1):20-5
http://www.asean-endocrinejournal.org/images/ISSUE1/issue%201_261_mustapha_malaysian%20dm%20cpg.pdf.
245. Suhaimi M. A cross-sectional study of erectile dysfunction amongst diabetic patients in Kota Bharu,
Kelantan. Jurnal Kesihatan Masyarakat 2001;7.
246. Sulaiman IM, Lee HS, Balan S, et al. Intraoperative glycaemic control in non insulin dependent diabetes
mellitus: A comparison between normal saline and Ringer's lactate. Medicine & health 2006;1(1):20-4
http://journalarticle.ukm.my/1847/1/04._20-24_(MH_010).pdf
247. Suresh S, Zunaina E, Shatriah I, et al. Sensitivity and specificity of HRT and OCT to detect diabetic macular
edema. Journal of Diabetes & Metabolism 2012;S3:009
http://omicsonline.org/2155-6156/2155-6156-S3-009.pdf.
248. Syed Azhar SS, Amer Hayat K, Abdul Razak AM, et al. Impact of diabetes mellitus on treatment outcomes
of tuberculosis patients in tertiary care setup. Am J Med Sci 2013;345(4):321-5
http://www.cap-tb.org/sites/default/files/documents/Gender.TB.DM.Malaysia.20123.pdf
249. Syed Shahzad H, Kaeshaelya T, Syed Imran A, et al. Pregnancy complications, mental health-related
problems and type 2 diabetes mellitus in Malaysian women. Diabetes Metab Syndr 2013;7(4):191-7
250. Syed Wasif G, Syed Azhar SS, Shameni S. Prediction and rate of infections in diabetes mellitus patients
with diabetes ketoacidosis in Penang, Malaysia. Open Journal of Epidemiology 2012;2:1-6
http://www.scirp.org/journal/PaperDownload.aspx?paperID=17233
251. Taghavi SM, Fatemi SS, Rokni H. Cabergoline effect on blood sugar in type 2 diabetic patients with oral
agent failure. Med J Malaysia 2012;67(4):390-2
http://www.e-mjm.org/2012/v67n4/Cabergoline.pdf
252. Tam CL, Bonn G, Yeoh SH, et al. Investigating diet and physical activity in Malaysia: education and family
history of diabetes relate to lower levels of physical activity. Front Psychol 2014;5:1328
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253661
253. Tan AE, Norizah WM, Hayati AR, et al. Umbilical artery resistance index in diabetic pregnancies: the
associations with fetal outcome and neonatal septal hypertrophic cardiomyopathy. J Obstet Gynaecol Res
2005;31(4):296-301
254. Tan CE, Emmanuel SC, Tan BY, et al. Diabetes mellitus abolishes ethnic differences in cardiovascular risk
factors: lessons from a multi-ethnic population. Atherosclerosis 2001;155(1):179-86
255. Tan F, Liew SF, Chan G, et al. Improving diabetes care in a public hospital medical clinic: report of a
completed audit cycle. J Eval Clin Pract 2011;17(1):40-4
256. Tan F, Chan G, Wong JS, et al. Standard of care for type 2 diabetic patients in a public hospital general
medical clinic: report of a self-audit. Med J Malaysia 2008;63(3):224-8
http://www.e-mjm.org/2008/v63n3/Type_2_Diabetic_Patients.pdf
257. Tan MY, Magarey JM, Chee WSS, et al. A brief structured education programme enhances self-care
practices and improves glycaemic control in Malaysians with poorly controlled diabetes. Health Educ Res
2011;26(5):896-907
http://her.oxfordjournals.org/content/26/5/896.full.pdf
258. Tan MY, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic
control. Patient Educ Couns 2008;72(2):252-67
259. Tan SM, Shafiee Z, Wu LL, et al. Factors associated with control of type I diabetes in Malaysian adolescents
and young adults. Int J Psychiatry Med 2005;35(2):123-36
260. Tan SF, Chia YC, Karuthan C. Rate of decline of kidney function in patients with type 2 diabetes mellitus
and the associated factors: A 10-year retrospective cohort study. Asia Pac J Public Health 2013
261. Tan SL, Juliana S, Sakinah H. Dietary compliance and its association with glycemic control among poorly
controlled type 2 diabetic outpatients in Hospital Universiti Sains Malaysia. Malays J Nutr 2011;17(3):28799
http://nutriweb.org.my/publications/mjn0017_3/2Tan%20SL.pdf
262. Tan BL, Lim TA. Factors influencing post-operative hyperglycaemia in type 2 diabetes mellitus patients
managed without intra-operative insulin. Med J Malaysia 2006;61(1):122-4
http://www.e-mjm.org/2006/v61n1/Diabetes_Mellitus.pdf
263. Tan MC, Wong TW, Ng OC, et al. Metabolic syndrome components and prevalence of cardiovascular
disease among type 2 diabetic patients in Malaysia. Southeast Asian J Trop Med Public Health
2014;45(1):226-35
264. Teo CW, Chung WL, Khaw CR, et al. Hypertension and diabetes mellitus among the residents of an old
folks home in north Malaysia. Internet Journal of Geriatrics and Gerontology 2009;6(1).
http://ispub.com/IJGG/6/1/12653
265. Thai AC, Mohan V, Khalid BA, et al. Islet autoimmunity status in Asians with young-onset diabetes (12-40
years): association with clinical characteristics, beta cell function and cardio-metabolic risk factors.
Diabetes Res Clin Pract 2008;80(2):224-30
266. Thevi T, Maslina B, Reddy SC. Prevalence of eye diseases and visual impairment among the rural
population - a case study of Temerloh Hospital. Malaysian Family Physician 2012;7(1):6-10
http://www.e-mfp.org/ojs/index.php/MFP/article/view/14
267. Vasanthakumar SS, Teng CL. EBM commentary: Should statins be started in all type 2 diabetics
irrespective of LDL-cholesterol level? Malaysian Family Physician 2007;2(2):75
http://www.emfp.org/2007v2n2/pdf/Should%20statins%20be%20started%20in%20all%20type%202%20diabetics%20ir
respective%20of%20LDL-cholesterol%20level.pdf;.
268. Vasudevan R, Ismail P, Stanslas J, et al. Association of insertion/deletion polymorphism of alphaadrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in Malaysian
subjects. Int J Biol Sci 2008;4(6):362-7
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567812
269. Wan Mohamad WB, Lim-Abrahan MA, Jain AB, et al. Safety and effectiveness of insulin aspart in type 2
diabetic patients: results from the ASEAN cohort of the A(1)chieve study. Diabetes Res Clin Pract 2013;100
Suppl 1:S17-23
http://www.a1chieve.com/en/article/S0168-8227%2813%2970005-6/aim/.
270. Wan Mohamad WB, Chow CC, Khalid AK, et al. Adding biphasic insulin aspart 30 once or twice daily is
more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes. Diabetes
Obes Metab 2007;9(5):724-32
271. Wan Mohamad WB, Tun Fizi A, Ismail RB, et al. Efficacy and safety of single versus multiple daily doses of
glibenclamide in type 2 diabetes mellitus. Diabetes Res Clin Pract 2000;49(2-3):93-9
272. Wan Nazaimoon WM, Siti Harnida MI, Wan Mohamad WB, et al. Prevalence of diabetes in Malaysia and
usefulness of HbA1c as a diagnostic criterion. Diabet Med 2013;30(7):825-8
http://www.researchgate.net/publication/235646155_Prevalence_of_diabetes_in_Malaysia_and_usefuln
ess_of_HbA(1c)_as_a_diagnostic_criterion/file/60b7d525f3526e098b.pdf.
273. Wan Nazaimoon WM, Kamarul Imran M, Amir Sharifuddin MK, et al. Prevalence of overweight and
obesity among adult Malaysians: an update. Asia Pac J Clin Nutr 2011;20(1):35-41
http://apjcn.nhri.org.tw/server/APJCN/20/1/35.pdf
274. Wan Nazaimoon WM, Suraiami M. Prevalence of diabetes, impared fasting glucose and metabolic
syndrome among female Orang Asli community in Peninsular Malaysia. Int J Diabetes Dev Ctries
2010;30(3):118-22
http://www.rssdi.in/diabetesbulletin/2010/JULY/IntJDiabDevCtries303118-296188_004921.pdf
275. Wan Norlida I, Aljunid SM, Aniza I. Cost of type 2 diabetes mellitus in selected developing countries.
Malaysian Journal of Public Health Medicine 2010;10(2):68-71
http://pppkam.org.my/mjphm/journals/Volume10.2/8.Cost%20of%20Type%202%20Diabetes%20(LASTT)(
68-71)M%20(Last).pdf
276. Wee HL, Li SC, Cheung YB, et al. The influence of ethnicity on health-related quality of life in diabetes
mellitus: a population-based, multiethnic study. J Diabetes Complications 2006;20(3):170-8.
277. Wee HL, Cheung YB, Li SC, et al. The impact of diabetes mellitus and other chronic medical conditions on
health-related Quality of Life: is the whole greater than the sum of its parts? Health Qual Life Outcomes
2005;3:2
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC548134
278. Wong KS, Hwang S, Han DC, et al. Losartan reduces the costs of diabetic end-stage renal disease: an Asian
perspective. Nephrology (Carlton) 2005;10(5):520-4
http://www.pkdiet.com/pdf/losartanreducesesrd.pdf
279. Wong SSL, Ng CJ, Liew SM, et al. Effectiveness of a colour coded HbA1c graphical record in improving
diabetes control in people with type 2 diabetes: a randomized control trial. Diabetes Res Clin Pract
2012;95(2):e41-4
280. Yahaya H, Al-Jabil SW, Noorizan AA, et al. Statin use prior to ischemic stroke onset is associated with
decreased in-hospital mortality. Fundam Clin Pharmacol 2011;25(3):388-94
http://staff.najah.edu/sites/default/files/Statin_Use_Prior_To_Ischemic_Stroke_Onset_Is_Associated_Wi
th_Decreased_In-Hospital_Mortality_0.pdf.
281. Yahaya H, Noorizan AA, Al-Jabil SW, et al. Impact of angiotensin-converting enzyme inhibitors
administration prior to acute ischemic stroke onset on in-hospital mortality. J Cardiovasc Pharmacol Ther
2010;15(3):274-81
ftp://82.239.144.183/bibli/-%20Revue%20Articles%20FB/Biblio%20101015%20rout%E9e/213.1009ACE%20inhibitors%20administration%20prior%20to%20acute%20ischemic%20stroke%20onset%20on%2
0in-hospital%20mortality_Hassan,%20J%20CV%20PT.pdf
282. Yeo CK, Hapizah MN, Khalid AK, et al. The comparison of QT dispersion and 24 hour ambulatory blood
pressure monitoring amongst diabetic patients with and without microalbuminuria. Med J Malaysia
2004;59(2):185-9
http://www.e-mjm.org/2004/v59n2/Diabetic_Patients.pdf
283. Yeo CK, Hapizah MN, Khalid BA, et al. New coronary risk factors: is there a difference between diabetic
patients with microalbuminuria compared to those without microalbuminuria? Med J Malaysia
2002;57(3):298-303
http://www.e-mjm.org/2002/v57n3/Coronary_Risk_Factors.pdf
284. Yunus R, Ariff AR, Shuaib IL, et al. A study of the factors related to intima-media thickness of the common
carotid artery amongst rural middle age individuals in Hospital Universiti Sains Malaysia. Southeast Asian J
Trop Med Public Health 2006;37(4):806-11
285. Yusof BNM, Talib RA, Kamaruddin NA, et al. A low-GI diet is associated with a short-term improvement of
glycaemic control in Asian patients with type 2 diabetes. Diabetes Obes Metab 2009;11(4):387-96
286. Zainal Ariffin O, Ismail ASM, Fatanah I, et al. The characteristic of metabolic syndrome risk factors among
respondents with diabetes mellitus in Perlis. NCD Malaysia 2005;4(3):3-7
287. Zainal Ariffin O, Radziah I, Ishak J. Communty-based programmes in diabetes control. NCD Malaysia
2002;1(2):12-5
288. Zaki NF, Sulaiman AS, Gillani WS. Clinical evaluation of dyslipidemia among type II diabetic patients at
public hospital Penang, Malaysia. Int Arch Med 2010;3:34,7682-3-34
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002890.
289. Zakuan ZD, Habsah H, Mohd Suhaimi AW, et al. The association between pre-morbid conditions and
respiratory tract manifestations amongst Malaysian Hajj pilgrims. Trop Biomed 2010;27(2):294-300
http://msptm.org/files/294_-_300_Zakuan_Zainy_Deris.pdf
290. Zaman Huri H, Permalu V, Vethakkan SR. Sliding-scale versus basal-bolus insulin in the management of
severe or acute hyperglycemia in type 2 diabetes patients: a retrospective study. PLoS One
2014;9(9):e106505
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152280
291. Zanariah H, Lim-Abrahan MA, Jain AB, et al. Switching from biphasic human insulin to biphasic insulin
aspart 30 in type 2 diabetes: results from the ASEAN subgroup of the A(1)chieve study. Diabetes Res Clin
Pract 2013;100 Suppl 1:S24-9
http://www.a1chieve.com/en/article/S0168-8227%2813%2970006-8/fulltext
PRIMARY CARE RESEARCH
1. Addoor KR, Bhandary SV, Khanna R, et al. Assessment of awareness of diabetic retinopathy among the
diabetics attending the peripheral diabetic clinics in Melaka, Malaysia. Med J Malaysia 2011;66(1):48-52
http://www.e-mjm.org/2011/v66n1/Diabetes_mellitus.pdf
2. Azura M, Adibah Hanim I, Juwita S. Risk factor of peripheral neuropathy among newly diagnosed type 2
diabetic patients in primary care clinic. International Journal of Collaborative Research on Internal
Medicine & Public Health 2012;4(11):1858-67
http://www.iomcworld.com/ijcrimph/files/v04-n11-05.pdf
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Azwany N, Aziz AI, Mohammad W. The impact of Ramadan fasting on hydration status of type 2 diabetics
in Kubang Kerian, Kelantan. Jurnal Kesihatan Masyarakat 2004;10:31-4
http://journalarticle.ukm.my/4436/1/2004-02nizam.pdf
Badariah A, Khalid AK, Anuar Zaini MZ, et al. Influencing factors of glycaemic control in patients attending
different types of urban health care settings in Malaysia. Diabetes Res Clin Pract 2011;93(1):e12-4
Chan GC. Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: are they
managed according to guidelines? Singapore Med J 2005;46(3):127-31
http://www.sma.org.sg/smj/4603/4603a3.pdf
Chan GC, Ghazali O, Khoo EM. Management of type 2 diabetes mellitus: is it in accordance with the
guidelines? Med J Malaysia 2005;60(5):578-84
http://www.e-mjm.org/2005/v60n5/Type_2_Diabetes_Mellitus.pdf
Chan SC, Lee TW, Teoh LC, et al. Audit on cardiovascular disease preventive care in general practice.
Singapore Med J 2008;49(4):311-5
http://smj.sma.org.sg/4904/4904a6.pdf
Chan SC. Has diabetic management in the Outpatient Department, Hospital Ipoh improved over the
years? Medical Practice Hospital Ipoh 2003;6(1):36-8
Cheah WL, Lee PY, Lim PY, et al. Perception of quality of life among people with diabetes. Malaysian
Family Physician 2012;7(2&3):21-30
http://e-mfp.org/issues/2012v7n2_3/Diabetes-quality-of-life.pdf
Cheong AT, Lee PY, Sazlina SG, et al. Poor glycemic control in younger women attending Malaysian public
primary care clinics: findings from adults diabetes control and management registry. BMC Fam Pract
2013;14:188,2296-14-188
http://www.biomedcentral.com/content/pdf/1471-2296-14-188.pdf
Cheong AT, Tong SF, Sazlina SG, et al. Blood pressure control among hypertensive patients with and
without diabetes mellitus in six public primary care clinics in Malaysia. Asia Pac J Public Health 2013
Cheong AT, Zaiton A, Chew BH. Metabolic control and cardiovascular risk factors among type 2 diabetes in
a primary care clinic. Malaysian Journal of Medicine and Health Sciences 2012;8(1):5-12
http://medic.upm.edu.my/images/stories/journal/VOL8NO1_JANUARI2012.pdf
Chew BH, Mastura I, Mohamad Adam B. Comparing the disease profiles of adult patients with type 2
diabetes mellitus attending four public health care facilities in Malaysia. Malaysian Family Physician
2013;8(1):11-8
http://www.e-mfp.org/pdf/2013v8n3/type-2-diabetes-mellitus.pdf
Chew BH, Sazlina SG, Lee PY, et al. Type 2 diabetes mellitus patient profiles, diseases control and
complications at four public health facilities - a cross-sectional study based on the Adult Diabetes Control
and Management (ADCM) registry 2009. Med J Malaysia 2013;68(5):397-404
http://www.e-mjm.org/2013/v68n5/type-2-diabetes-mellitus.pdf
Chew BH, Sazlina SG, Mastura I, et al. Age >/= 60 years was an independent risk factor for diabetesrelated complications despite good control of cardiovascular risk factors in patients with type 2 diabetes
mellitus. Exp Gerontol 2013;48(5):485-91
Chew BH, Cheong AT, Zaiton A, et al. Men suffer more complications from diabetes than women despite
similar glycaemic control and a better cardiovascular risk profile: the ADCM study 2008. Journal of Men's
Health 2012;9(3):190-7
Chew BH, Mastura I, Lee PY, et al. Determinants of uncontrolled dyslipidaemia among adult type 2
diabetes in Malaysia: the Malaysian Diabetes Registry 2009. Diabetes Res Clin Pract 2012;96(3):339-47
Chew BH, Mastura I, Sazlina SG, et al. Determinants of uncontrolled hypertension in adult type 2 diabetes
mellitus: an analysis of the Malaysian diabetes registry 2009. Cardiovasc Diabetol 2012;11:54,2840-11-54
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434063
Chew BH, Palikat JM, Nur Syamimi A, et al. An audit of type 2 diabetes care in a Malaysian public
community polyclinic. Pertanika Journal of Science & Technology 2012;20(1):97-102
http://www.pertanika2.upm.edu.my/Pertanika%20PAPERS/JST%20Vol.%2020%20%281%29%20Jan.%202
012/14%20Pg%2097-102.pdf
20. Chew BH, Khoo EM, Chia YC. Does religious affiliation influence glycaemic control in primary care patients
with type 2 diabetes mellitus? Ment Health Fam Med 2011;8(1):21-8
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134210
21. Chew BH, Khoo EM, Chia YC. Social support and glycemic control in adult patients with type 2 diabetes
mellitus. Asia Pac J Public Health
2011;http://www.researchgate.net/publication/51924846_Social_Support_and_Glycemic_Control_in_Ad
ult_Patients_With_Type_2_Diabetes_Mellitus/file/32bfe5101de9823433.pdf.
22. Chew BH, Khoo EM, Chia YC. Quality of care for adult type 2 diabetes mellitus at a university primary care
centre in Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health
2011;3(6):439-49
http://iomcworld.com/ijcrimph/files/v03-n06-03.pdf
23. Chew BH, Mastura I, Lee PY, et al. Ethnic differences in glycaemic control and complications: the adult
diabetes control and management (ADCM), Malaysia. Med J Malaysia 2011;66(3):244-8
http://www.e-mjm.org/2011/v66n3/Glycaemic_control.pdf
24. Chew BH, Mastura I, Cheong AT, et al. Diabetic hypertensive control and treatment: A descriptive report
from the audit diabetes control and management (ADCM) registry. Malaysian Family Physician
2010;5(3):134-9
http://www.e-mfp.org/2010v5n3/pdf/diabetic_hypertensive.pdf
25. Ching SM, Zainul Amiruddin Z, Fuziah P, et al. Complementary alternative medicine use among patients
with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC
Complement Altern Med 2013;13:148,6882-13-148
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701537
26. Chua SS, Kok LC, Faridah Aryani MY, et al. Pharmaceutical care issues identified by pharmacists in patients
with diabetes, hypertension or hyperlipidaemia in primary care settings. BMC Health Serv Res
2012;12:388,6963-12-388
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529120
27. Ding CH, Teng CL, Koh CN. Knowledge of diabetes mellitus among diabetic and non-diabetic patients in
Klinik Kesihatan Seremban. Med J Malaysia 2006;61(4):399-404
http://www.e-mjm.org/2006/v61n4/Knowledge_Diabetes_Mellitus.pdf
28. Draman S, Aris MAM, Razman, et al. Mas Cotek (Ficus deltoidea): a possible supplement for type II
diabetes: (a pilot study). Pertanika Journal of Tropical Agricultural Science 2012;35(1):93-102
http://www.pertanika2.upm.edu.my/Pertanika%20PAPERS/JTAS%20Vol.%2035%20%281%29%20Feb.%20
2012/17%20Pg%2093-102.pdf
29. Faridah K, Azmi MT. Retrospective study of predictors for foot ulceration among diabetic patients
attending Kuala Langat Health Centre from 1999 to 2008. Jurnal Kesihatan Masyarakat 2009;15(2):43-59
http://journalarticle.ukm.my/276/1/1.pdf
30. Fauziah MN, Suhaiza S. A review of diabetic complications amongst poorly controlled diabetes at 8 health
clinics in Kelantan. NCD Malaysia 2004;3(2):13-6
31. Feisul Idzwan M, Mohd Idris MN. Incidence of microalbuminuria and its influencing factors among
patients with type 2 diabetes at Klinik Kesihatan Seremban, Malaysia, from 2000 until 2005. International
Medical Journal (Tokyo) 2008;15(4):249-55
32. Gurpreet K, Tee GH, Suthahar A, et al. Depression, anxiety and stress symptoms among diabetics in
Malaysia: a cross sectional study in an urban primary care setting. BMC Fam Pract 2013;14:69,2296-14-69
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669622
33. Hasliza AH, Hizlinda T, Rahmah MA, et al. Factors influencing insulin acceptance among type 2 diabetes
mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract 2013;14(1):164
http://www.biomedcentral.com/content/pdf/1471-2296-14-164.pdf
34. Hasni I, Adibah Hanim I, Shaiful Bahari I, et al. The use of HbA1C in the diagnosis of diabetes mellitus type
2 in high risk subjects. International Journal of Diabetes & Metabolism 2010;18:25-8
http://ijod.uaeu.ac.ae/iss_1801/e.pdf
35. Hassan NH, Juwita S, Azidah AK, et al. Study on the effect of oral hypoglycaemic agents on arterial
stiffness among Malays with type II diabetes mellitus . International Journal of Diabetes & Metabolism
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
2007;15:116-20
http://ijod.uaeu.ac.ae/iss_1801/e.pdf
Keah RSH, Ch'ng KS. Prevalence of diabetic retinopathy in a primary care setting using digital retinal
imaging technology. Malaysian Family Physician 2006;1(1):19-22
http://www.e-mfp.org/old/v1n1/pdf/diabetic_retinopathy.pdf
Khatoon R, Khoo EM. Prevalence of peripheral arterial disease in patients with diabetes mellitus in a
primary care setting. Med J Malaysia 2007;62(2):130-3
http://www.e-mjm.org/2007/v62n2/Peripheral_Arterial_Disease.pdf
Kong NC, Chia YC, Khalid AK, et al. Microalbuminuria prevalence study in hypertensive type 2 diabetic
patients in Malaysia. Med J Malaysia 2006;61(4):457-65
http://www.e-mjm.org/2006/v61n4/Microalbuminuria.pdf
Lee PY, Cheong AT, Zaiton A, et al. Does ethnicity contribute to the control of cardiovascular risk factors
among patients with type 2 diabetes? Asia Pac J Public Health 2013;25(4):316-25
Lee PY, Lee YK, Ng CJ. How can insulin initiation delivery in a dual-sector health system be optimised? A
qualitative study on healthcare professionals' views. BMC Public Health 2012;12:313
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533841
Lee TW, Chan SC, Chua WT, et al. Audit of diabetes mellitus in general practice. Med J Malaysia
2004;59(3):317-22
http://www.e-mjm.org/2004/v59n3/Audit_of_Diabetes_Mellitus.pdf
Lee YK, Ng CJ, Lee PY, et al. What are the barriers faced by patients using insulin? A qualitative study of
Malaysian health care professionals' views. Patient Prefer Adherence 2013;7:103-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559078/pdf/ppa-7-103.pdf
Lee YK, Lee PY, Ng CJ. A qualitative study on healthcare professionals' perceived barriers to insulin
initiation in a multi-ethnic population. BMC Fam Pract 2012;13:28,2296-13-28
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389339
Leelavathi M, Noor Azimah M, Kharuddin NF, et al. Prevalence of toenail onychomycosis among diabetics
at a primary care facility in Malaysia. Southeast Asian J Trop Med Public Health 2013;44(3):479-83
http://www.tm.mahidol.ac.th/seameo/2013-44-3-full/15-5647-6.pdf
Leelavathi M, Noor Azimah M, Kharuddin NF, et al. Microorganisms responsible for onychomycosis among
diabetic patients. [Mikroganisama penyebab jangkitan kulat kuku kalangan pesakit kencing manis.]. Sains
Malaysiana 2013;42(3):359-63
http://www.ukm.my/jsm/pdf_files/SM-PDF-42-3-2013/12%20M.%20Leelavathi.pdf
Liew SM, Lee PY, Nik Sherina Haidi H, et al. Statins use is associated with poorer glycaemic control in a
cohort of hypertensive patients with diabetes and without diabetes. Diabetol Metab Syndr
2014;6:53,5996-6-53. eCollection 2014
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003286
Lim CJ, Suzana S, Hanis Mastura Y, et al. Level of nutritional knowledge and health awareness among
diabetes mellitus patients at cheras health clinic, Kuala Lumpur, Malaysia. Sains Malaysiana
2010;39(3):505-11
http://www.ukm.my/jsm/pdf_files/SM-PDF-39-3-2010/24%20Lim%20Ching.pdf
Low CF, Eusni Rahayu MT, Chong PP, et al. Adiponectin SNP45TG is associated with gestational diabetes
mellitus. Arch Gynecol Obstet 2011;283(6):1255-60
http://www.researchgate.net/publication/232292935_MATERNOFETAL_MEDICINE_Adiponectin_SNP45TG_is_associated_with_gestational_diabetes_mellitus/file/9fcfd50
817ddd9255c.pdf
Low WHH, Seet W, Anis Safura R, et al. Community-based cardiovascular Risk Factors Intervention
Strategies (CORFIS) in managing hypertension: A pragmatic non-randomised controlled trial. Med J
Malaysia 2013;68(2):129-35
http://www.e-mjm.org/2013/v68n2/CORFIS-in-managing-hypertension.pdf
Mafauzy M. Diabetes control and complications in private primary healthcare in Malaysia. Med J Malaysia
2005;60(2):212-7
http://www.e-mjm.org/2005/v60n2/Diabetes_Control.pdf
51. Mallika P, Aziz S, Goh PP, et al. Diabetic retinopathy in native and non-native Sarawakians--findings from
the Diabetic Eye Registry. Med J Malaysia 2012;67(4):369-74
http://www.e-mjm.org/2012/v67n4/Diabetic-retinopathy.pdf
52. Mallika PS, Lee PY, Cheah WL, et al. Risk factors for diabetic retinopathy in diabetics screened using
fundus photography at a primary health care setting in east Malaysia. Malaysian Family Physician
2011;6(2&3):60-5
http://www.e-mfp.org/2011v6n2_3/pdf/risk_of_diabetic_retinopathy.pdf
53. Mariam M, Osman A. An Intervention study of exercise-Qigong program on quality of life and
cardiovasular risk factor control among type 2 diabites mellitus patient at Beranang Health Center, Hulu
Langat. Borneo Journal of Medical Sciences 2007;1.
54. Mastura I, Teng CL, Mimi O, et al. Usage of glucometer is associated with improved glycaemic control in
type 2 diabetes mellitus patients in Malaysian public primary care clinics: an open-label, randomised
controlled trial. Singapore Med J 2013;54(7):391-5
http://www.sma.org.sg/UploadedImg/files/SMJ/5407/5407a3.pdf
55. Mastura I, Chew BH, Lee PY, et al. Control and treatment profiles of 70,889 adult type 2 diabetes mellitus
patients in Malaysia - a cross sectional survey in 2009. International Journal of Collaborative Research on
Internal Medicine & Public Health 2011;3(1):98-113
http://www.iomcworld.com/ijcrimph/files/v03-n01-10.pdf.
56. Mastura I, Mimi O, Piterman L, et al. Self-monitoring of blood glucose among diabetes patients attending
government health clinics. Med J Malaysia 2007;62(2):147-51
http://www.e-mjm.org/2007/v62n2/Self-Monitoring_Blood_Glucose.pdf
57. Mimi O, Teng CL, Chia YC. Clinical tests for diabetic peripheral neuropathy - which modality to choose?
FMS Malaysia 2004;2(1):11-3.
58. Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med
J Malaysia 2003;58(4):533-8
http://www.e-mjm.org/2003/v58n4/Diabetic_Peripheral_Neuropathy.pdf
59. Mohd Faudzi A, Norsiah MN, Siti Zubaidah MA, et al. Validation of the comprehensive ICF core sets for
diabetes mellitus:a Malaysian perspective. Ann Acad Med Singapore 2011;40(4):168-78
http://www.annals.edu.sg/pdf/40VolNo4Apr2011/V40N4p168.pdf
60. Moy FM, Suriah AR. Anthropometry and dietary intake of type 2 diabetes patients attending an outpatient
clinic. Malays J Nutr 2002;8(1):63-73
http://nutriweb.org.my/publications/mjn008_1/mjn8n1_art5.pdf
61. Nabila A, M.Dzaki S, Zainal Ariffin O, et al. Direct costs of diabetes in an outpatient setting in Malaysia.
NCD Malaysia 2003;2(1):19-27.
62. Nazimah I, Che Hatikah CH, Murizah MZ, et al. Universal versus selective screening for detection of
gestational diabetes mellitus in a Malaysian population. Malaysian Family Physician 2009;4(2&3):83-7
http://www.e-mfp.org/old/2009v4n2_3/pdf/gestational_diabetes_mellitus.pdf
63. Nik Sherina Haidi H, Teng CL, Mohd Shajahan MY. Continuity of care of diabetic patients in a family
practice clinic: How important is it? Asia Pac Fam Med 2003;2(1):10-5
http://www.apfmj-archive.com/afm2.1/afm_044.pdf
64. Noor Azimah M, Radzniwan AR, Zuhra H, et al. Have we done enough with diabetic education? A pilot
study. Malaysian Family Physician 2010;5(1):24-30
http://www.e-mfp.org/2010v5n1/pdf/Diabetic_education.pdf
65. Noor Salihah Z, Lua PL, Nik Mazlan M. Body weight satisfaction: association with weight control practices
among type 2 diabetic patients. Malays J Nutr 2011;17(1):55-66
http://nutriweb.org.my/publications/mjn0017_1/salihahLua%28%285%29%28edSP%29%28RV%29rev.pdf
66. Nor Shazwani MN, Suzana S, Hanis Mastura Y, et al. Assessment of physical activity level among
individuals with type 2 diabetes mellitus at Cheras Health Clinic, Kuala Lumpur. Malays J Nutr
2010;16(1):101-12
http://nutriweb.org.my/publications/mjn0016/Shazwani(edSP)101-112.pdf
67. Norhafizah S, Tahir A, Ahmad Sharifuddin MA, et al. Oral health seeking behaviour among Malaysians with
type II diabetes. Journal of Public Health Aspects 2014;http://www.hoajonline.com/journals/pdf/20557205-1-1.pdf
68. Norma S, Azmi MT, Rotina A. Factors that influence albuminuria among type 2 diabetes mellitus at
primary healthcare clinics in Negeri Sembilan 2007. Jurnal Kesihatan Masyarakat 2010;16(1):21-32
http://journalarticle.ukm.my/265/1/1.pdf.
69. Nur Azmiah Z, Zulkarnain AK, Tahir A. Psychological insulin resistance (PIR) among type 2 diabetes patients
at public health clinics in Federal Territory of Malaysia. International Medical Journal (IIUM) 2011;10(2):712
http://iiumedic.net/imjm/v1/download/Volume%2010%20No%202/IMJM%20Vol%2010%20No%202%20
p09-14.pdf
70. Nur Sufiza A, Farida I, Paraidathathu T. Factors associated with good glycemic control among patients with
type 2 diabetes mellitus. J Diabetes Investig 2014;5(5):563-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188115
71. Nur Sufiza A, Azuana R, Farida I, et al. Medication adherence in patients with type 2 diabetes mellitus
treated at primary health clinics in Malaysia. Patient Prefer Adherence 2013;7:525-30
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693921
72. Omar M, Mariam AM. Monitoring of cardiovascular screening programme and combined
diabetic/hypertensive clinic: experience from the districts. NCD Malaysia 2002;1(1):28-31
73. Ooi CP, Loke SC, Zaiton A, et al. Cross-sectional study of older adults with type 2 diabetes mellitus in two
rural public primary healthcare facilities in Malaysia. Med J Malaysia 2011;66(2):108-12
http://www.e-mjm.org/2011/v66n2/Type_2_Diabetes_Mellitus.pdf
74. Rabia K, Khoo EM. Is the Edinburgh Claudication Questionnaire a good screening tool for detection of
peripheral arterial disease in diabetic patients? Asia Pac Fam Med
2007;6(1)http://www.apfmj.com/afm6_1/afm54_.pdf
75. Rahmah MA, Noraishah J. Determinants of glucose control among elderly diabetics in Kulim. Medicine &
health 2011;6(2):78-85
http://www.ppukm.ukm.my/ukmmcjournal
76. Ranjini A, Subashini A, Ling HM. A knowledge, attitude and practice (KAP) study of diabetes mellitus
among patients attending Klinik Kesihatan Seri Manjung. NCD Malaysia 2003;2(2):6-16
77. Reddy SC, Kihn YM, Nurjahan MI, et al. Retinopathy in type 2 diabetic patients with microalbuminuria.
Nepal J Ophthalmol 2013;5(1):69-74
http://nepjol.info/index.php/NEPJOPH/article/view/7830/6389
78. Remli R, Chan SC. Use of complementary medicine amongst diabetic patients in a public primary care
clinic in Ipoh. Med J Malaysia 2003;58(5):688-93
http://www.e-mjm.org/2003/v58n5/Complementary_Medicine.pdf
79. Rohana D, Wan Norlida WI, Nor Azwany Y, et al. Economic evaluation of type 2 diabetes management at
the Malaysian Ministry of Health primary care clinics, in Machang, Kelantan. Malaysian Journal of Public
Health Medicine 2007;7(1):5-13
http://www.mjphm.org.my/mjphm/journals/Volume%207%20(1)%20:%202007/5-13.pdf
80. Rosediani M, Azidah AK, Mafauzy M. Correlation between fasting plasma glucose, post prandial glucose
and glycated haemoglobin and fructosamine. Med J Malaysia 2006;61(1):67-71
http://www.e-mjm.org/2006/v61n1/Plasma_Glucose.pdf
81. Sazlina K, Siti Balkis B, Yau M, et al. Relationship between sensory neuropathy and body imbalance among
diabetic Malay women. Sains Malaysiana 2011;40(8):945-51
http://www.ukm.my/jsm/pdf_files/SM-PDF-40-8-2011/18%20Sazlina.pdf
82. Sazlina K, Hatta S, Matthew Y, et al. Sexual function of Malay women with type 2 diabetes mellitus: a
preliminary study. ASEAN Journal of Psychiatry 2010;11(1):64-71
http://www.aseanjournalofpsychiatry.org/pdf/ASEAN_3_15.pdf
83. Sazlina SG, Mastura I, Zaiton A, et al. Control of glycemia and other cardiovascular disease risk factors in
older adults with type 2 diabetes mellitus: Data from the Adult Diabetes Control and Management.
Geriatr Gerontol Int 2014;14(1):130-7
84. Sazlina SG, Zailinawati AH, Zaiton A, et al. A clinical audit on diabetes care in two urban public primary
care clinics in Malaysia. Malaysian Journal of Medicine and Health Sciences 2010;6(1):101-9
http://medic.upm.edu.my/images/stories/journal/VOL6NO1_JANUARY2010.pdf
85. Shahidan H, Noorlia Y, Azlina I, et al. Diabetic management: home-based versus chinic-based plasma
glucose monitoring. NCD Malaysia 2003;2(4):7-10
86. Sharifa Ezat WP, Azimatun Noor A, Amrizal M, et al. Economic burden of diabetic care in government
health facilities in Selangor. Jurnal Kesihatan Masyarakat 2009;15(2):17-26
http://journalarticle.ukm.my/273/1/1.pdf
87. Shekhar KC, Achike FI, Gurpreet K, et al. A preliminary evaluation of the efficacy and safety of Cogent db
(an ayurvedic drug) in the glycemic control of patients with type 2-diabetes. J Altern Complement Med
2002;8(4):445-57
88. Sherina MS, Jefferelli SB, Zaiton A, et al. A study on the association of depression and chronic disease
among elderly patients attending a primary care clinic. Malaysian Journal of Psychiatry 2002;10(1):8-12
89. Suhaiza S, Ahmad Nasir M, Jeriah I, et al. Glycaemic control among type 2 diabetic patients in Kelantan.
NCD Malaysia 2004;3(3):2-5
90. Tan CE, Tohit N, Shamsul A, Shah, et al. Chronic kidney disease stage 3B among Malaysian diabetics in
primary care and its associated factors: a pilot 5-year case control study. Medicine & health 2013;8(2):5563
http://www.medicineandhealthukm.com/system/files/article/2014/MS173.pdf
91. Tan MY. The relationship of health beliefs and complication prevention behaviors of Chinese individuals
with type 2 diabetes mellitus. Diabetes Res Clin Pract 2004;66(1):71-7
92. Umi A, Md. Idris MN, Osman A. Risk factors for diabetic nephropathy among non-insulin dependent
patients who attended City Hall's Staff Clinic in Kuala Lumpur. Malaysian Journal of Public Health Medicine
2001;1:16-21
http://www.mjphm.org.my/mjphm/journals/Volume%201%20:%202001/16-21.pdf.
93. Wong JS, Tan F, Lee PY. The state of lipid control in patients with diabetes in a public health care centre.
Asia Pac J Public Health 2007;19(3):16-21
94. Wong JS. Proteinuria in diabetic patients in a primary health care setting in Sarawak. Med J Malaysia
2005;60(2):146-50
http://www.e-mjm.org/2005/v60n2/Proteinuria.pdf
95. Wong JS, Rahimah N. Glycaemic control of diabetic patients in an urban primary health care setting in
Sarawak: the Tanah Puteh Health Centre experience. Med J Malaysia 2004;59(3):411-7
http://www.e-mjm.org/2004/v59n3/Glycaemic_Control_Diabetic.pdf
96. Yong SP, Siti Balkis B, Sazlina K. Foot sensation status of Malay women with type 2 diabetes mellitus.
Jurnal Sains Kesihatan Malaysia 2012;10(2):43
http://journalarticle.ukm.my/6366/1/43-47.pdf
97. Zaki Morad MZ, Robaayah Z, Chan SP, et al. Optimal cut-off levels to define obesity: body mass index and
waist circumference, and their relationship to cardiovascular disease, dyslipidaemia, hypertension and
diabetes in Malaysia. Asia Pac J Clin Nutr 2009;18(2):209-16
http://apjcn.nhri.org.tw/server/APJCN/18/2/209.pdf
Case reports
1. Chan AC, Rohan MJ, Hamid A, et al. Emphysematous pyelonephritis in a diabetic patient with pelvicureteric stone. Med J Malaysia 2007;62(2):166-7
http://www.e-mjm.org/2007/v62n2/Emphysematous_Pyelonephritis.pdf.
2. Cheong B. Metformin: a differential diagnosis for weight loss, altered bowel habits and B12 deficiency
anemia in an elderly diabetic. Med J Malaysia 2013;68(5):441-2
3. Dinesh RG, Avatar S, Haron A, et al. Nasal septal abscess with uncontrolled diabetes mellitus: case reports.
Med J Malaysia 2011;66(3):253-4
http://www.e-mjm.org/2011/v66n3/Nasal_septal_abscess.pdf.
4. Helmi S, Sasheela P, Mun KS, et al. Cervical abscesses due to co-infection with Burkholderia pseudomallei,
Salmonella enterica serovar Stanley and Mycobacterium tuberculosis in a patient with diabetes mellitus.
BMC Infect Dis 2013;13:527,2334-13-527
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829705/.
5. Kamaliah MD, Bhajan MA, Dzarr GA. Emphysematous pyelonephritis caused by Candida infection.
Southeast Asian J Trop Med Public Health 2005;36(3):725-7.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Kumar S, Yushak AW, Gul YA. Intra-abdominal haemangiopericytoma associated with uncontrolled
diabetes mellitus. Med J Malaysia 2004;59(3):425-7
http://www.e-mjm.org/2004/v59n3/Hemangiopericytoma.pdf
Lim S, Norlisah R, Tai SML, et al. Involuntary movements in an elderly woman with recently diagnosed
diabetes. J Clin Neurosci 2011;18(4):539, 590
Mohd Hadzri H, Azarisman Shah MS, Suhaimi A, et al. Disseminated histoplasmosis presenting with
chronic ulcerative tongue lesions in a patient with diabetes. BMJ Case Rep
2010;2010:10.1136/bcr.06.2010.3120
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029345
Mohd Hadzri H, Azarisman Shah MS, Fauzi AR, et al. Invasive rhinocerebral mucormycosis with orbital
extension in poorly-controlled diabetes mellitus. Singapore Med J 2009;50(3):e107-9
http://smj.sma.org.sg/5003/5003cr7.pdf
Murty OP. Diabetic artefacts in forensic practice. J Forensic Leg Med 2009;16(4):218-23.
Neetu G, Pathmanathan R, Weng NK. Diabetic mastopathy: a case report and literature review. Case Rep
Oncol 2010;3(2):245-51
http://www.karger.com/Article/Pdf/318641
Norlinah MI, Ngow HA, Hamidon B. Angioinvasive cerebral aspergillosis presenting as acute ischaemic
stroke in a patient with diabetes mellitus. Singapore Med J 2007;48(1):e1-4
http://smj.sma.org.sg/4801/4801cr1.pdf
Ong YC, Su LH, Anuar Zaini MZ. Reversal of metabolic dysfunction through polyvalent pharmacotherapyaugmented lifestyle intervention: case reports. Journal of Diabetes & Metabolism 2011;2(5):1000133
http://omicsonline.org/2155-6156/2155-6156-2-133.pdf
Sathya K, Balamanikandasrinivasan C, Senthilkumar M, et al. Thermal burn of palate in an elderly diabetic
patient. Gerodontology 2014;31(2):149-52
Saw A, Kwan MK, Sengupta S. Necrotising fasciitis: a life-threatening complication of acupuncture in a
patient with diabetes mellitus. Singapore Med J 2004;45(4):180-2
http://www.sma.org.sg/smj/4504/4504cr1.pdf
Shalini B, Salmah W, Tharakan J. Diabetic non-ketotic hyperglycemia and the hemichorea-hemiballism
syndrome: A report of four cases. Neurology Asia 2010;15(1):89-91
http://www.neurology-asia.org/articles/20101_089.pdf
Sherina MS, Rozali A. Dietary management of a patient with diabetes mellitus: a case report. Malays J
Nutr 2003;9(2):137-44
http://nutriweb.org.my/publications/mjn009_2/mjn9n2_art6.pdf
Sherina MS, Shiran MS. Psychosocial issues in an adolescent with diabetes mellitus. Family Physician
2003;12(2):17-8
Venugopal B, Wong KT, Goto YI, et al. Mitochondrial disorder, diabetes mellitus, and findings in three
muscles, including the heart. Ultrastruct Pathol 2006;30(3):135-41